JP2017048158A - Makeup cosmetic - Google Patents
Makeup cosmetic Download PDFInfo
- Publication number
- JP2017048158A JP2017048158A JP2015174696A JP2015174696A JP2017048158A JP 2017048158 A JP2017048158 A JP 2017048158A JP 2015174696 A JP2015174696 A JP 2015174696A JP 2015174696 A JP2015174696 A JP 2015174696A JP 2017048158 A JP2017048158 A JP 2017048158A
- Authority
- JP
- Japan
- Prior art keywords
- component
- makeup
- powder
- extract
- silicone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 71
- 239000000049 pigment Substances 0.000 claims abstract description 49
- 239000002245 particle Substances 0.000 claims abstract description 23
- 150000004706 metal oxides Chemical class 0.000 claims abstract description 20
- 229910044991 metal oxide Inorganic materials 0.000 claims abstract description 19
- 239000011164 primary particle Substances 0.000 claims abstract description 13
- 230000001747 exhibiting effect Effects 0.000 claims abstract description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 60
- 239000010419 fine particle Substances 0.000 claims description 24
- 239000004408 titanium dioxide Substances 0.000 claims description 20
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 14
- 239000011787 zinc oxide Substances 0.000 claims description 7
- 230000005661 hydrophobic surface Effects 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 24
- 230000007547 defect Effects 0.000 abstract description 12
- 239000011148 porous material Substances 0.000 abstract description 10
- 239000000843 powder Substances 0.000 description 55
- -1 perfluoroalkyl phosphate ester Chemical class 0.000 description 48
- 229920001296 polysiloxane Polymers 0.000 description 46
- 239000000284 extract Substances 0.000 description 40
- 239000003921 oil Substances 0.000 description 36
- 239000000203 mixture Substances 0.000 description 27
- 239000010445 mica Substances 0.000 description 26
- 229910052618 mica group Inorganic materials 0.000 description 26
- 235000019198 oils Nutrition 0.000 description 26
- 230000000052 comparative effect Effects 0.000 description 21
- 239000012071 phase Substances 0.000 description 19
- 239000004205 dimethyl polysiloxane Substances 0.000 description 18
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 18
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 18
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 17
- 239000010936 titanium Substances 0.000 description 17
- 229910052719 titanium Inorganic materials 0.000 description 17
- 229940008099 dimethicone Drugs 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 14
- 235000014113 dietary fatty acids Nutrition 0.000 description 14
- 238000011156 evaluation Methods 0.000 description 14
- 239000000194 fatty acid Substances 0.000 description 14
- 229930195729 fatty acid Natural products 0.000 description 14
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 12
- 239000008346 aqueous phase Substances 0.000 description 9
- 239000000839 emulsion Substances 0.000 description 9
- 230000003595 spectral effect Effects 0.000 description 8
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 239000003995 emulsifying agent Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000006096 absorbing agent Substances 0.000 description 6
- 150000004665 fatty acids Chemical class 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 150000005846 sugar alcohols Polymers 0.000 description 6
- 239000000454 talc Substances 0.000 description 6
- 229910052623 talc Inorganic materials 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 239000003242 anti bacterial agent Substances 0.000 description 5
- 239000000975 dye Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 239000012860 organic pigment Substances 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- 235000021355 Stearic acid Nutrition 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 238000010306 acid treatment Methods 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 239000011247 coating layer Substances 0.000 description 4
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 4
- 229960005323 phenoxyethanol Drugs 0.000 description 4
- 229920002545 silicone oil Polymers 0.000 description 4
- 239000008117 stearic acid Substances 0.000 description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 4
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 3
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000002421 anti-septic effect Effects 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000012937 correction Methods 0.000 description 3
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 150000002431 hydrogen Chemical class 0.000 description 3
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 3
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 3
- 239000002649 leather substitute Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- 239000003002 pH adjusting agent Substances 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 239000003352 sequestering agent Substances 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229920003169 water-soluble polymer Polymers 0.000 description 3
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 2
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- 229910052582 BN Inorganic materials 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 2
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical class OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- 240000000731 Fagus sylvatica Species 0.000 description 2
- 235000010099 Fagus sylvatica Nutrition 0.000 description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- YRXGUZPUZBCGST-UHFFFAOYSA-N [2-(hydroxymethoxy)phenyl]-phenylmethanone Chemical compound OCOC1=CC=CC=C1C(=O)C1=CC=CC=C1 YRXGUZPUZBCGST-UHFFFAOYSA-N 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 229940114081 cinnamate Drugs 0.000 description 2
- 235000017471 coenzyme Q10 Nutrition 0.000 description 2
- 229940110767 coenzyme Q10 Drugs 0.000 description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 2
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 description 2
- 229960000735 docosanol Drugs 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- MTZQAGJQAFMTAQ-UHFFFAOYSA-N ethyl benzoate Chemical compound CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 230000036074 healthy skin Effects 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- VAMFXQBUQXONLZ-UHFFFAOYSA-N icos-1-ene Chemical compound CCCCCCCCCCCCCCCCCCC=C VAMFXQBUQXONLZ-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940100554 isononyl isononanoate Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- YZUUTMGDONTGTN-UHFFFAOYSA-N nonaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCO YZUUTMGDONTGTN-UHFFFAOYSA-N 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 229960001679 octinoxate Drugs 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 2
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 2
- 229910052628 phlogopite Inorganic materials 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- 238000002834 transmittance Methods 0.000 description 2
- QPQANCNBWQXGTQ-UHFFFAOYSA-N trihydroxy(trimethylsilylperoxy)silane Chemical compound C[Si](C)(C)OO[Si](O)(O)O QPQANCNBWQXGTQ-UHFFFAOYSA-N 0.000 description 2
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 2
- 239000007762 w/o emulsion Substances 0.000 description 2
- DEQUKPCANKRTPZ-UHFFFAOYSA-N (2,3-dihydroxyphenyl)-phenylmethanone Chemical compound OC1=CC=CC(C(=O)C=2C=CC=CC=2)=C1O DEQUKPCANKRTPZ-UHFFFAOYSA-N 0.000 description 1
- HJIAMFHSAAEUKR-UHFFFAOYSA-N (2-hydroxyphenyl)-phenylmethanone Chemical compound OC1=CC=CC=C1C(=O)C1=CC=CC=C1 HJIAMFHSAAEUKR-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- IRVNEGRHQKGRGD-WPXUHFOISA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;hexadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O IRVNEGRHQKGRGD-WPXUHFOISA-N 0.000 description 1
- PBTPTBMYJPCXRQ-MGMRMFRLSA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;hexadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O PBTPTBMYJPCXRQ-MGMRMFRLSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- GYDYJUYZBRGMCC-INIZCTEOSA-N (2s)-2-amino-6-(dodecanoylamino)hexanoic acid Chemical compound CCCCCCCCCCCC(=O)NCCCC[C@H](N)C(O)=O GYDYJUYZBRGMCC-INIZCTEOSA-N 0.000 description 1
- PAFJZWHXMSQJKV-UQZRNVAESA-N (3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol;octadecanoic acid Chemical compound OC[C@@H](O)C1OC[C@H](O)[C@H]1O.OC[C@@H](O)C1OC[C@H](O)[C@H]1O.OC[C@@H](O)C1OC[C@H](O)[C@H]1O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O PAFJZWHXMSQJKV-UQZRNVAESA-N 0.000 description 1
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 1
- AFDXODALSZRGIH-QPJJXVBHSA-N (E)-3-(4-methoxyphenyl)prop-2-enoic acid Chemical compound COC1=CC=C(\C=C\C(O)=O)C=C1 AFDXODALSZRGIH-QPJJXVBHSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical class C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- NOCQLJFADATJHV-UHFFFAOYSA-N 2,2,3,3,4-pentaethylhexanoic acid Chemical compound C(C)C(C(C(C(=O)O)(CC)CC)(CC)CC)CC NOCQLJFADATJHV-UHFFFAOYSA-N 0.000 description 1
- OCIQZTICBOLUJQ-UHFFFAOYSA-N 2,2,3,3-tetraethylhexanoic acid Chemical compound CCCC(CC)(CC)C(CC)(CC)C(O)=O OCIQZTICBOLUJQ-UHFFFAOYSA-N 0.000 description 1
- XEOYAIXXFJNMIR-UHFFFAOYSA-N 2,2-diethylhexanoic acid;2,2-dimethylpropane-1,3-diol Chemical compound OCC(C)(C)CO.CCCCC(CC)(CC)C(O)=O XEOYAIXXFJNMIR-UHFFFAOYSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- JPWUIQIFCDAWQX-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(O)CO JPWUIQIFCDAWQX-UHFFFAOYSA-N 0.000 description 1
- WHQOKFZWSDOTQP-UHFFFAOYSA-N 2,3-dihydroxypropyl 4-aminobenzoate Chemical compound NC1=CC=C(C(=O)OCC(O)CO)C=C1 WHQOKFZWSDOTQP-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- OPJWPPVYCOPDCM-UHFFFAOYSA-N 2-ethylhexyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC OPJWPPVYCOPDCM-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 1
- LVYLCBNXHHHPSB-UHFFFAOYSA-N 2-hydroxyethyl salicylate Chemical compound OCCOC(=O)C1=CC=CC=C1O LVYLCBNXHHHPSB-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241001237961 Amanita rubescens Species 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- WYQGPWYOMGJVDX-UHFFFAOYSA-N COC(=C(C(=O)OC(C)C)OC)C1=CC=CC=C1 Chemical compound COC(=C(C(=O)OC(C)C)OC)C1=CC=CC=C1 WYQGPWYOMGJVDX-UHFFFAOYSA-N 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- 244000019459 Cynara cardunculus Species 0.000 description 1
- 235000019106 Cynara scolymus Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 229910001111 Fine metal Inorganic materials 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 241000546188 Hypericum Species 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 241000226556 Leontopodium alpinum Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- GWFGDXZQZYMSMJ-UHFFFAOYSA-N Octadecansaeure-heptadecylester Natural products CCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC GWFGDXZQZYMSMJ-UHFFFAOYSA-N 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 101000611641 Rattus norvegicus Protein phosphatase 1 regulatory subunit 15A Proteins 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 240000008077 Ruellia tuberosa Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 241000269851 Sarda sarda Species 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- FGUZFFWTBWJBIL-XWVZOOPGSA-N [(1r)-1-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O FGUZFFWTBWJBIL-XWVZOOPGSA-N 0.000 description 1
- NCHJGQKLPRTMAO-XWVZOOPGSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NCHJGQKLPRTMAO-XWVZOOPGSA-N 0.000 description 1
- AQKOHYMKBUOXEB-RYNSOKOISA-N [(2R)-2-[(2R,3R,4S)-4-hydroxy-3-(16-methylheptadecanoyloxy)oxolan-2-yl]-2-(16-methylheptadecanoyloxy)ethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCC(C)C)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCC(C)C AQKOHYMKBUOXEB-RYNSOKOISA-N 0.000 description 1
- IJCWFDPJFXGQBN-RYNSOKOISA-N [(2R)-2-[(2R,3R,4S)-4-hydroxy-3-octadecanoyloxyoxolan-2-yl]-2-octadecanoyloxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCCCC IJCWFDPJFXGQBN-RYNSOKOISA-N 0.000 description 1
- WUBKCBOQNXUQDU-UHFFFAOYSA-N [2-(dihydroxymethoxy)phenyl]-phenylmethanone Chemical compound OC(O)OC1=CC=CC=C1C(=O)C1=CC=CC=C1 WUBKCBOQNXUQDU-UHFFFAOYSA-N 0.000 description 1
- SVRHJWALMLOXMI-UHFFFAOYSA-N [2-(dihydroxymethoxy)phenyl]-phenylmethanone;sodium Chemical compound [Na].OC(O)OC1=CC=CC=C1C(=O)C1=CC=CC=C1 SVRHJWALMLOXMI-UHFFFAOYSA-N 0.000 description 1
- GLLSGHWYBGERSE-UHFFFAOYSA-N [2-(hydroxymethoxy)phenyl]-phenylmethanone;sodium Chemical compound [Na].OCOC1=CC=CC=C1C(=O)C1=CC=CC=C1 GLLSGHWYBGERSE-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000016520 artichoke thistle Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229910052626 biotite Inorganic materials 0.000 description 1
- 229940094978 bis-peg-18 methyl ether dimethyl silane Drugs 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 235000012730 carminic acid Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940059958 centella asiatica extract Drugs 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 235000020230 cinnamon extract Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000019646 color tone Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 229940090934 diphenylsiloxy phenyl trimethicone Drugs 0.000 description 1
- YGANSGVIUGARFR-UHFFFAOYSA-N dipotassium dioxosilane oxo(oxoalumanyloxy)alumane oxygen(2-) Chemical compound [O--].[K+].[K+].O=[Si]=O.O=[Al]O[Al]=O YGANSGVIUGARFR-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical compound [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- VPWFPZBFBFHIIL-UHFFFAOYSA-L disodium 4-[(4-methyl-2-sulfophenyl)diazenyl]-3-oxidonaphthalene-2-carboxylate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1N=NC1=C(O)C(C([O-])=O)=CC2=CC=CC=C12 VPWFPZBFBFHIIL-UHFFFAOYSA-L 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000010985 glycerol esters of wood rosin Nutrition 0.000 description 1
- 229960002389 glycol salicylate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical class O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229940038487 grape extract Drugs 0.000 description 1
- 229940065115 grapefruit extract Drugs 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000020717 hawthorn extract Nutrition 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- SDPBXXCJVDQPIQ-UHFFFAOYSA-N hexadecyl hexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC SDPBXXCJVDQPIQ-UHFFFAOYSA-N 0.000 description 1
- 238000009775 high-speed stirring Methods 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 229940045809 horse chestnut seed Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 238000007561 laser diffraction method Methods 0.000 description 1
- 229940091554 lauryl peg-9 polydimethylsiloxyethyl dimethicone Drugs 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229940105112 magnesium myristate Drugs 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- DMRBHZWQMKSQGR-UHFFFAOYSA-L magnesium;tetradecanoate Chemical compound [Mg+2].CCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCC([O-])=O DMRBHZWQMKSQGR-UHFFFAOYSA-L 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- SOXAGEOHPCXXIO-DVOMOZLQSA-N menthyl anthranilate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1N SOXAGEOHPCXXIO-DVOMOZLQSA-N 0.000 description 1
- 229960002248 meradimate Drugs 0.000 description 1
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229910052627 muscovite Inorganic materials 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- NKBWPOSQERPBFI-UHFFFAOYSA-N octadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC NKBWPOSQERPBFI-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004482 other powder Substances 0.000 description 1
- 239000010330 ougon Substances 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- AFDXODALSZRGIH-UHFFFAOYSA-N p-coumaric acid methyl ether Natural products COC1=CC=C(C=CC(O)=O)C=C1 AFDXODALSZRGIH-UHFFFAOYSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 150000002948 pantothenic acids Chemical class 0.000 description 1
- 229940117336 parsley extract Drugs 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 229940088608 peg-9 polydimethylsiloxyethyl dimethicone Drugs 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 229960000969 phenyl salicylate Drugs 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920003217 poly(methylsilsesquioxane) Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229940062000 polyglyceryl-2 triisostearate Drugs 0.000 description 1
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 239000001044 red dye Substances 0.000 description 1
- 229940077082 red pepper extract Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 239000010667 rosehip oil Substances 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 229940112950 sage extract Drugs 0.000 description 1
- 235000020752 sage extract Nutrition 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940037001 sodium edetate Drugs 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 229940057429 sorbitan isostearate Drugs 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 235000011078 sorbitan tristearate Nutrition 0.000 description 1
- 239000001589 sorbitan tristearate Substances 0.000 description 1
- 229960004129 sorbitan tristearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- 229960001325 triclocarban Drugs 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 229940117972 triolein Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000012463 white pigment Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000009538 yokuinin Substances 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Images
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明はメイクアップ化粧料に関する。本発明は、詳しくは、シミや毛穴、くすみなどの肌の欠点を目立たなくさせ、且つ、肌に透明感を与えるメイクアップ化粧料に関し、自然な仕上がりを可能にし、且つ、その化粧効果の持続性に優れたメイクアップ化粧料に関する。 The present invention relates to a makeup cosmetic. More particularly, the present invention relates to a makeup cosmetic that makes skin defects such as spots, pores and dullness inconspicuous and gives the skin a sense of transparency, enabling a natural finish and maintaining the makeup effect. The present invention relates to makeup cosmetics with excellent properties.
ファンデーションやコンシーラー等のメイクアップ化粧料は、シミや毛穴、くすみなどの肌の欠点のある箇所の肌色や凹凸を補正し、目立たなくさせる効果を有する。近年では、肌の欠点を隠しながらも肌に透明感を与え、自然な仕上がりを可能とし、また、このような化粧効果をより長く持続させることが可能なメイクアップ化粧料が求められてきている。 Make-up cosmetics such as foundations and concealers have the effect of correcting the skin color and unevenness of spots with skin defects such as spots, pores and dullness, and making them inconspicuous. In recent years, there has been a demand for makeup cosmetics that can provide skin with a transparent feeling while hiding skin imperfections, enable a natural finish, and can maintain such makeup effects for a longer period of time. .
メイクアップ化粧料は、隠蔽力を向上させるために、例えば二酸化チタンや酸化鉄等の屈折率の高い着色顔料を多く配合することが一般的である。しかしながら、このようなメイクアップ化粧料では、肌表面に形成される化粧膜が「マット」となり、透明感や自然なつやを有する化粧膜を得ることが困難となる場合があった。 In general, makeup cosmetics generally contain a large amount of a color pigment having a high refractive index such as titanium dioxide or iron oxide in order to improve the hiding power. However, in such makeup cosmetics, the cosmetic film formed on the skin surface becomes a “mat”, and it may be difficult to obtain a cosmetic film having a sense of transparency and natural gloss.
一方、メイクアップ化粧料は、肌に外観の美しさや塗布時の光沢感を付与するために、例えば雲母に酸化チタンを被覆した雲母チタン等のパール顔料を配合することがある。このパール顔料は、雲母表面に被覆する酸化チタンの膜厚によって種々の色調を得ることができ、また、光沢感を呈するため、好適に用いられる。しかしながら、雲母チタンは、光沢感は高いが、干渉光の彩度が低い。 On the other hand, makeup cosmetics sometimes contain, for example, pearl pigments such as mica titanium in which mica is coated with titanium oxide in order to give the skin a beautiful appearance and a glossy feeling when applied. This pearl pigment can be suitably used because it can obtain various color tones depending on the film thickness of titanium oxide coated on the surface of mica and exhibits a glossy feeling. However, titanium mica has a high glossiness but a low saturation of interference light.
干渉光の彩度が低いという雲母チタンの特性を改善する手法として、例えば特許文献1において、赤色有機色素で被覆された雲母チタンが提案されており、これを配合したファンデーションを塗布することで、くすみのない自然で健康的な肌色を取り戻すことが記載されている。
As a technique for improving the characteristics of mica titanium that the saturation of interference light is low, for example,
しかしながら、特許文献1の方法を用いた化粧料は、有機色素被覆雲母チタンとともに配合される屈折率の高い二酸化チタンを多くすると、有機色素被覆雲母チタンの光沢感も隠蔽されてしまうことがあった。また、二酸化チタンの量に合わせて、有機色素被覆雲母チタンの配合も多くすると、肌表面に形成される化粧膜中の有機色素被覆雲母チタンの有機色素が、経時で皮脂等によって影響され赤くくすむという現象が生じ、塗布した直後の化粧効果が持続しにくくなる場合があった。さらに、有機色素被覆雲母チタンを乳化化粧料に用いた場合は、保存安定性にも影響を与える。例えば、乳化化粧料中の二酸化チタンや有機色素被覆雲母チタン等の粉体の配合量を増やすと、粉体の分散性が悪くなったり、長期的な保存安定性を確保することが難しくなる場合があった。
However, in the cosmetic using the method of
メイクアップ化粧料において、肌の欠点を補正するカバー力(隠蔽力)を向上させるためには、屈折率の高い顔料級二酸化チタンを多く配合しなければならない。この場合、塗布後の肌を自然で健康な肌色とするためにさらに雲母チタンを配合しても、顔料級二酸化チタンによって雲母チタンの光沢感も隠蔽されてしまうことがあった。このように、肌の欠点における肌色や凹凸を補正する効果に優れながらも、透明感を与え、自然な仕上がりが得られる化粧料を開発することは困難であった。 In makeup cosmetics, in order to improve the covering power (hiding power) for correcting skin defects, a large amount of pigment-grade titanium dioxide having a high refractive index must be blended. In this case, even when titanium mica is further added to make the skin after application natural and healthy skin color, the glossiness of titanium mica may be masked by pigment grade titanium dioxide. As described above, it has been difficult to develop a cosmetic that is excellent in the effect of correcting skin color and unevenness in the defect of the skin but gives a transparent feeling and a natural finish.
本発明の目的は、シミや毛穴、くすみなどの肌の欠点を隠しながらも、肌に透明感を与え、自然な仕上がりを可能とし、また、このような化粧効果をより長く持続させることが可能なメイクアップ化粧料を提供することである。 The object of the present invention is to conceal skin defects such as spots, pores, and dullness, while giving the skin a sense of transparency, enabling a natural finish, and making this makeup effect last longer. Is to provide clean makeup cosmetics.
すなわち、本発明は、メイクアップ化粧料であって、成分(A)平均粒子径が1.0〜15.0μmの橙色又は赤色の干渉色を呈する1種又は2種以上のパール顔料と、成分(B)平均一次粒子径が0.05μm〜0.12μmの範囲にある微粒子金属酸化物とを含有する。 That is, the present invention is a makeup cosmetic, wherein component (A) is one or more pearl pigments exhibiting an orange or red interference color having an average particle diameter of 1.0 to 15.0 μm, and a component. (B) containing a fine particle metal oxide having an average primary particle diameter in the range of 0.05 μm to 0.12 μm.
前記成分(A)が、疎水化した表面を有するパール顔料であることが好ましい。 The component (A) is preferably a pearl pigment having a hydrophobic surface.
前記成分(B)が、微粒子二酸化チタン、微粒子酸化亜鉛、又はこれらの組み合わせから選択されることが好ましい。 The component (B) is preferably selected from fine particle titanium dioxide, fine particle zinc oxide, or a combination thereof.
前記メイクアップ化粧料の総質量を基準として、前記成分(A)が0.5〜10.0質量%、前記成分(B)が1.0〜15.0質量%であることが好ましい。 It is preferable that the component (A) is 0.5 to 10.0% by mass and the component (B) is 1.0 to 15.0% by mass based on the total mass of the makeup cosmetic.
前記メイクアップ化粧料が、ファンデーション、化粧下地、又はコンシーラーであることが好ましい。 The makeup cosmetic is preferably a foundation, a makeup base, or a concealer.
本発明に係るメイクアップ化粧料によれば、シミや毛穴、くすみなどの肌の欠点を隠しながらも、肌に透明感を与えることができ、自然な仕上がりを可能とする。透明感は、通常、光が肌を透過し、内部散乱を経て放出されるによって達成されるものであり、マット感(厚塗り感)がない状態である。従来、このような、肌の欠点のカバー力と透明感とは両立困難な特性であったところ、本発明に係るメイクアップ化粧料によれば、パール顔料として平均粒子径が1.0〜15.0μmの橙色又は赤色の干渉色を呈するものを使用すると共に、微粒子金属酸化物として平均一次粒子径が0.05μm〜0.12μmの範囲にあるものを使用することで、光の特性を効果的に制御してカバー力と透明感を両立することが可能になり、また、上述した化粧効果をより長く持続させることが可能である。 According to the makeup cosmetic according to the present invention, the skin can be transparent while concealing skin defects such as spots, pores, and dullness, and a natural finish is possible. The translucency is usually achieved by light being transmitted through the skin and emitted through internal scattering, and is in a state where there is no matte feeling (thick feeling). Conventionally, the covering power and transparency of such skin defects were difficult to achieve at the same time. However, according to the makeup cosmetics according to the present invention, the average particle diameter is 1.0 to 15 as a pearl pigment. 0.03 μm orange or red interference color is used, and fine metal oxides with an average primary particle diameter in the range of 0.05 μm to 0.12 μm are used to improve the light characteristics. It is possible to control both the covering power and the transparency, and it is possible to maintain the above-described makeup effect for a longer time.
以下に、本発明の実施の形態を説明する。但し、本発明は、以下に説明する実施の形態によって限定されるものではない。本発明の一実施形態によれば、メイクアップ化粧料であって、成分(A)と成分(B)を少なくとも含有する。 Hereinafter, embodiments of the present invention will be described. However, the present invention is not limited to the embodiments described below. According to one embodiment of the present invention, it is a makeup cosmetic and contains at least the component (A) and the component (B).
[成分(A)]
成分(A)は、平均粒子径が1.0〜15.0μmの橙色〜赤色の干渉色を呈する1種又は2種以上のパール顔料である。パール顔料は、真珠光沢やメタリック感のある外観を有する粉末状の顔料である。パール顔料としては、一般的に、例えば、雲母チタン、オキシ塩化ビスマス、魚鱗箔等が挙げられ、特に、雲母チタンが好適である。雲母チタンは、平滑な薄片状粒子とした雲母の表面に、酸化チタンの層を被覆したものである。雲母としては、白雲母、黒雲母、金雲母、合成金雲母等が挙げられる。また、雲母の代わりに、ガラス末やアルミ、タルク、シリカなどを母粉体としたパール顔料であってもよい。さらに、雲母又は母粉末表面上の被覆層を、酸化チタンの代わりに酸化鉄で被覆したもの、及び、雲母又は母粉末表面の酸化チタン等の被覆層の上に、さらに酸化鉄等を被覆したものもパール顔料として用いてもよい。このように、成分(A)として用いるパール顔料は、酸化チタン等で所定の干渉色を呈するようにした干渉パール顔料であり、色素を被覆したパール顔料は含まない。
[Component (A)]
The component (A) is one or more pearl pigments exhibiting an orange to red interference color having an average particle diameter of 1.0 to 15.0 μm. The pearl pigment is a powdered pigment having a pearly luster or metallic appearance. Examples of the pearl pigment generally include mica titanium, bismuth oxychloride, fish scale foil, and the like, and particularly mica titanium is preferable. Titanium mica is obtained by coating a surface of mica made of smooth flaky particles with a titanium oxide layer. Examples of mica include muscovite, biotite, phlogopite, and synthetic phlogopite. Further, instead of mica, a pearl pigment using glass powder, aluminum, talc, silica or the like as a mother powder may be used. Furthermore, a coating layer on the surface of mica or mother powder is coated with iron oxide instead of titanium oxide, and a coating layer of titanium oxide or the like on the surface of mica or mother powder is further coated with iron oxide or the like. Those may also be used as pearl pigments. Thus, the pearl pigment used as the component (A) is an interference pearl pigment that exhibits a predetermined interference color with titanium oxide or the like, and does not include a pearl pigment coated with a dye.
成分(A)として用いるパール顔料は、平均粒子径が1.0〜15.0μmの範囲にあり、より好ましくは、5.0〜10.0μmである。平均粒子径が1.0μmより小さいと、所定の干渉色を呈するのが難しく、また、メイクアップ化粧料として肌表面に塗布する際の肌滑りやつっぱり感などの感触が悪くなる。平均粒子径が15μmより大きいと、パール顔料の輝度が高くなり、点在感が生じ、化粧膜が不自然な仕上がりとなり、肌の凹凸を目立たせてしまう。ここで、平均粒子径は、レーザー回折法によって測定した粒度分布における積算値50%に対応する粒子径として求めたものである。 The pearl pigment used as the component (A) has an average particle size in the range of 1.0 to 15.0 μm, and more preferably 5.0 to 10.0 μm. When the average particle size is smaller than 1.0 μm, it is difficult to exhibit a predetermined interference color, and the feeling such as skin slipping and tension when applied to the skin surface as a makeup cosmetic is deteriorated. If the average particle size is larger than 15 μm, the brightness of the pearl pigment is increased, a dotted feeling is generated, the decorative film is unnaturally finished, and the unevenness of the skin is conspicuous. Here, the average particle diameter is obtained as a particle diameter corresponding to an integrated value of 50% in the particle size distribution measured by the laser diffraction method.
成分(A)として用いるパール顔料は、橙色又は赤色の干渉色を呈する。パール顔料の干渉色は、パール顔料から反射される反射光(干渉光)の色であり、パール顔料の外観を目視で確認した色であってもよい。干渉色は、例えば雲母チタンの場合、酸化チタン等の被覆層の厚みによって色が変化する。酸化チタンの被覆層の厚みは、橙色〜赤色の干渉色が得られれば特に限定されるものではなく、例えば10〜1000nmの範囲で適宜選択してもよい。橙色〜赤色の干渉色は、例えば、波長が580〜780nmとなる反射光の色である。 The pearl pigment used as component (A) exhibits an orange or red interference color. The interference color of the pearl pigment is a color of reflected light (interference light) reflected from the pearl pigment, and may be a color obtained by visually confirming the appearance of the pearl pigment. For example, in the case of mica titanium, the interference color changes depending on the thickness of the coating layer such as titanium oxide. The thickness of the titanium oxide coating layer is not particularly limited as long as an orange to red interference color is obtained, and may be appropriately selected within a range of, for example, 10 to 1000 nm. The interference color of orange to red is, for example, the color of reflected light having a wavelength of 580 to 780 nm.
成分(A)として用いるパール顔料は、580nm〜780nmの波長領域において分光反射スペクトルの反射率が特に高くなることが好ましい。具体的には、波長が570nm〜780nmの可視光に対する反射率が、好ましくは20%以上、より好ましくは40%以上であり、波長が610nm〜780nmの可視光に対する反射率が、好ましくは25%以上、より好ましくは45%以上である。成分(A)として用いるパール顔料の、可視光線領域内(380nm〜780nm)における反射率の変化は、分光反射率曲線で表すことができる。この分光反射率曲線は、所定の波長領域で反射率が最小値となる凹部を1箇所含み、凹部から短波長側に向かって反射率が増大し、また、凹部から長波長側に向かって反射率が増大することが好ましい。例えば、波長が460〜480nmあるいは500〜520nmの範囲における分光反射率曲線は、反射率が25%以下あるいか15%以下となる凹部を有していてもよい。例えば、凹部が460〜480nmの波長領域にある場合、380〜460nm及び480〜580nmの波長領域での反射率は、25〜40%の範囲であることが好ましい。例えば、凹部が500〜520nmの波長領域にある場合、380〜460nmの波長領域での反射率は、20〜35%の範囲であることが好ましく、460〜500nm及び520〜580nmの波長領域での反射率は、15〜20%の範囲であることが好ましい。反射率の測定は、例えば、成分(A)として用いるパール顔料を黒色人工皮革上に1mg/cm2となるように塗布して作製したサンプルを用いて、分光測色計によって、可視光線領域内(380nm〜780nm)における分光反射率を測定してもよい。また、成分(A)として用いるパール顔料は、L*a*b*表色系に基づく明度(L*値)が40〜80であることが好ましい。明度(L*値)は、例えば、上述した手法と同様にして、黒色人工皮革上に1mg/cm2となるように塗布して作製したサンプルを用いて、色彩色差計によって測定してもよい。 The pearl pigment used as component (A) preferably has a particularly high spectral reflectance reflectance in the wavelength region of 580 nm to 780 nm. Specifically, the reflectance for visible light having a wavelength of 570 nm to 780 nm is preferably 20% or more, more preferably 40% or more, and the reflectance for visible light having a wavelength of 610 nm to 780 nm is preferably 25%. More preferably, it is 45% or more. The change in reflectance in the visible light region (380 nm to 780 nm) of the pearl pigment used as the component (A) can be represented by a spectral reflectance curve. This spectral reflectance curve includes one concave portion having a minimum reflectance in a predetermined wavelength region, the reflectance increases from the concave portion toward the short wavelength side, and reflects from the concave portion toward the long wavelength side. The rate is preferably increased. For example, the spectral reflectance curve in the wavelength range of 460 to 480 nm or 500 to 520 nm may have a recess with a reflectance of 25% or less or 15% or less. For example, when the concave portion is in the wavelength region of 460 to 480 nm, the reflectance in the wavelength region of 380 to 460 nm and 480 to 580 nm is preferably in the range of 25 to 40%. For example, when the concave portion is in the wavelength region of 500 to 520 nm, the reflectance in the wavelength region of 380 to 460 nm is preferably in the range of 20 to 35%, and in the wavelength region of 460 to 500 nm and 520 to 580 nm. The reflectance is preferably in the range of 15 to 20%. The reflectance is measured by, for example, using a sample prepared by applying a pearl pigment used as component (A) on black artificial leather so as to have a concentration of 1 mg / cm 2, and using a spectrocolorimeter in the visible light region. Spectral reflectance at (380 nm to 780 nm) may be measured. The pearl pigment used as component (A) preferably has a lightness (L * value) of 40 to 80 based on the L * a * b * color system. The lightness (L * value) may be measured with a color difference meter using, for example, a sample prepared by applying 1 mg / cm 2 on black artificial leather in the same manner as described above. .
本発明に用いるパール顔料は、市販品をそのまま用いてもよい。本発明で用いるパール顔料として使用できる具体的な市販品の商品名としては、「ロナフレア バランスレッド」、「ティミロンシルクレッド」(以上、メルク社製)、「フラメンコシルクレッド」、「フラメンコシルクオレンジ」(以上、BASF社製)、「ヘリオスR10R」(トピー工業社製)、「プレステージソフトオレンジ」、「プレステージシルクオレンジ」、「プレステージソフトレッド」、「プレステージシルクレッド」(以上、ECKART社製)、「シャロンマイクロレッド」(CQV社製)等が挙げられ、これらを1種又は2種以上用いることができる。 As the pearl pigment used in the present invention, a commercially available product may be used as it is. Specific commercial products that can be used as pearl pigments in the present invention include "Lona Flare Balance Red", "Timilon Silk Red" (manufactured by Merck), "Flamenco Silk Red", "Flamenco Silk Orange". "(Above, manufactured by BASF)," Helios R10R "(produced by Topy Industries, Ltd.)," Prestige Soft Orange "," Prestige Silk Orange "," Prestige Soft Red "," Prestige Silk Red "(above, manufactured by ECKART) , “Sharon Micro Red” (manufactured by CQV) and the like, and one or more of them can be used.
本発明に用いるパール顔料は、疎水化した表面を有することが特に好ましい。パール顔料の表面を疎水化する手法としては、メチルポリシロキサン等によるシリコーン処理、パーフルオロアルキルリン酸エステル等によるフッ素処理、N−アシルグルタミン酸等によるアミノ酸処理、レシチン処理、金属石鹸処理、脂肪酸処理、及び、アルキルリン酸エステル処理等が挙げられるがこれらに限定されない。例えばシリコーン処理は、特に限定されることなく、一般的な手法を適用することができるが、以下のようにして行ってもよい。パール顔料とメチルハイドロジェンポリシロキサンやジメチルポリシロキサン等のシリコーン化合物とからなる処理粉体(パール顔料に対するシリコーン化合物の量は、好ましくは0.1〜20質量%である)を、例えばシリコーン化合物が0.3〜50質量%となる量のイソプロパノール又はヘキサンに溶かした後、例えばヘンシェルミキサーを用いて室温で撹拌して混合物を得る。次に、この混合物を100℃の乾燥機中に入れて溶媒を蒸発させて粉末化した後に、この粉末を予め260〜500℃に設定した電気炉内に入れて1〜24時間加熱を行い、シリコーン処理粉末としてもよい。 The pearl pigment used in the present invention particularly preferably has a hydrophobic surface. As a method of hydrophobizing the surface of the pearl pigment, silicone treatment with methylpolysiloxane, fluorine treatment with perfluoroalkyl phosphate ester, amino acid treatment with N-acyl glutamic acid, lecithin treatment, metal soap treatment, fatty acid treatment, Examples of the treatment include, but are not limited to, alkyl phosphate treatment. For example, the silicone treatment is not particularly limited, and a general method can be applied, but it may be performed as follows. A treated powder comprising a pearl pigment and a silicone compound such as methylhydrogenpolysiloxane or dimethylpolysiloxane (the amount of the silicone compound relative to the pearl pigment is preferably 0.1 to 20% by mass), for example, a silicone compound After dissolving in 0.3-50 mass% of isopropanol or hexane, the mixture is obtained by stirring at room temperature using, for example, a Henschel mixer. Next, after this mixture is put into a dryer at 100 ° C. to evaporate the solvent and pulverized, the powder is put in an electric furnace previously set at 260 to 500 ° C. and heated for 1 to 24 hours, Silicone-treated powder may be used.
成分(A)のパール顔料の含有量は、メイクアップ化粧料の総質量を基準として、好ましくは0.5〜10.0質量%、より好ましくは1.0〜7.0質量%、さらにより好ましくは2.0〜5.0質量%である。含有量が0.5質量%より少ないと、肌表面に塗布した際に透明感のある自然な仕上がりにならない場合がある。含有量が10.0質量%を超えると、肌表面に塗布した際に化粧膜のつやが過剰となる傾向がある。 The content of the pearl pigment of component (A) is preferably 0.5 to 10.0% by mass, more preferably 1.0 to 7.0% by mass, and even more based on the total mass of the makeup cosmetic. Preferably it is 2.0-5.0 mass%. When the content is less than 0.5% by mass, there is a case where a natural finish with a transparent feeling is not obtained when applied to the skin surface. When the content exceeds 10.0% by mass, the gloss of the decorative film tends to be excessive when applied to the skin surface.
[成分(B)]
成分(B)は、平均一次粒子径が0.05μm〜0.12μmの範囲にある微粒子金属酸化物である。微粒子金属酸化物は、メイクアップ化粧料に配合し得る金属酸化物であれば、その種類は特段限定されない。金属酸化物の例示としては、二酸化チタン、酸化亜鉛、酸化ジルコニウム及び酸化セリウム等が挙げられる。触媒活性を抑える目的で、これらの金属酸化物の表面にシリカやアルミナ等の無機化合物を被覆した微粒子金属酸化物を用いてもよい。また、微粒子金属酸化物は、紫外線防御効果に優れるという点から、微粒子二酸化チタン及び微粒子酸化亜鉛からなる群から選択される少なくとも1種を含むことが好ましい。
[Component (B)]
Component (B) is a fine particle metal oxide having an average primary particle size in the range of 0.05 μm to 0.12 μm. The type of the particulate metal oxide is not particularly limited as long as it is a metal oxide that can be blended into the makeup cosmetic. Examples of metal oxides include titanium dioxide, zinc oxide, zirconium oxide and cerium oxide. For the purpose of suppressing the catalytic activity, a fine particle metal oxide in which an inorganic compound such as silica or alumina is coated on the surface of these metal oxides may be used. In addition, the fine particle metal oxide preferably contains at least one selected from the group consisting of fine particle titanium dioxide and fine particle zinc oxide from the viewpoint of excellent ultraviolet protection effect.
成分(B)として用いる微粒子金属酸化物は、平均一次粒子径が0.05μm〜0.12μmの範囲にある。平均一次粒子径が0.05μmより小さいと、透明性が高くなり隠蔽力が低くなることから、肌表面に塗布した際に肌の欠点をカバーしにくくなる。平均一次粒子径が0.12μmより大きいと、隠蔽力は高いが、可視光の透過率が低くなることから、肌表面に塗布した際に透明感のある仕上がりとなりにくい。ここで、平均一次粒子径は、走査型電子顕微鏡による観察によって測定した一次粒子径の数平均粒子径である。平均一次粒子径が0.05μm〜0.12μmの範囲にある微粒子金属酸化物は、可視光領域において、短波長側を制御しながら、長波長側は光を透過しやすい性質を持つことから、成分(A)のパール顔料の干渉光である橙色〜赤色の反射光を隠蔽することなく、肌の欠点のみをカバーする効果に適している。 The fine particle metal oxide used as the component (B) has an average primary particle diameter in the range of 0.05 μm to 0.12 μm. When the average primary particle size is smaller than 0.05 μm, the transparency becomes high and the hiding power becomes low, so that it becomes difficult to cover the skin defects when applied to the skin surface. When the average primary particle size is larger than 0.12 μm, the hiding power is high, but the transmittance of visible light is low, so that it is difficult to achieve a transparent finish when applied to the skin surface. Here, the average primary particle diameter is the number average particle diameter of the primary particle diameter measured by observation with a scanning electron microscope. Since the fine particle metal oxide having an average primary particle diameter in the range of 0.05 μm to 0.12 μm has a property of easily transmitting light on the long wavelength side while controlling the short wavelength side in the visible light region, It is suitable for the effect of covering only the skin defects without concealing the orange-red reflected light which is the interference light of the component (A) pearl pigment.
微粒子金属酸化物の形状は、球状、略球状、不定形状、紡錘状、棒状、針状、短冊状及び板状等が挙げられるが、特に限定されるものではない。本発明で用いる微粒子金属酸化物は、メイクアップ化粧料に配合した際に、一次粒子として挙動するもの、また、造粒させて凝集粒子として挙動するもののいずれもが用いることができる。 Examples of the shape of the fine particle metal oxide include a spherical shape, a substantially spherical shape, an indefinite shape, a spindle shape, a rod shape, a needle shape, a strip shape, and a plate shape, but are not particularly limited. The fine particle metal oxide used in the present invention may be any of those that behave as primary particles when blended in a makeup cosmetic and those that behave as aggregated particles after being granulated.
本発明に用いる微粒子金属酸化物は、特に限定されないが、疎水化処理されているものを用いてもよい。例えば、入手時にその表面が疎水化されていない微粒子金属酸化物を、化粧料を製造する工程の中で疎水化処理してもよい。疎水化処理の方法としては、メチルポリシロキサン等によるシリコーン処理、パーフルオロアルキルリン酸エステル等によるフッ素処理、N−アシルグルタミン酸等によるアミノ酸処理、レシチン処理、金属石鹸処理、脂肪酸処理、及び、アルキルリン酸エステル処理等が挙げられるが、これらに限定されない。 The fine particle metal oxide used in the present invention is not particularly limited, but may be a hydrophobized one. For example, a fine particle metal oxide whose surface is not hydrophobized at the time of acquisition may be subjected to a hydrophobizing treatment in a process for producing a cosmetic. Hydrophobic treatment methods include silicone treatment with methylpolysiloxane, fluorine treatment with perfluoroalkyl phosphate, amino acid treatment with N-acyl glutamic acid, lecithin treatment, metal soap treatment, fatty acid treatment, and alkylphosphorus. Examples include acid ester treatment, but are not limited thereto.
本発明で用いる微粒子金属酸化物として使用できる具体的な市販品の商品名としては、例えば、微粒子二酸化チタンとしては、「TTO−80(A)」、「TTO−A−3」、「TTO−D−1」、「TTO−D−2」、「MPT−140」、「MPT−141」、「MPT−142」(以上、石原産業社製)、「MT−600B」、「MT−600SA」、「MT−700B」、「MT−700Z」、「MT−700BS」(以上、テイカ社製)等が挙げられ、また、例えば、微粒子酸化亜鉛としては、「MZ−200」、「MZY−203S」、「MZY−210M3S」、「MZ−150」、「MZ−153S」(以上、テイカ社製)が挙げられ、これらを1種又は2種以上用いることができる。 As a trade name of the concrete commercial item which can be used as the fine particle metal oxide used in the present invention, for example, as fine particle titanium dioxide, “TTO-80 (A)”, “TTO-A-3”, “TTO— D-1 "," TTO-D-2 "," MPT-140 "," MPT-141 "," MPT-142 "(manufactured by Ishihara Sangyo Co., Ltd.)," MT-600B "," MT-600SA " , “MT-700B”, “MT-700Z”, “MT-700BS” (manufactured by Teika Co., Ltd.) and the like, and examples of the fine particle zinc oxide include “MZ-200”, “MZY-203S”. ”,“ MZY-210M3S ”,“ MZ-150 ”,“ MZ-153S ”(manufactured by Teica), and one or more of them can be used.
成分(B)の微粒子金属酸化物の含有量は、メイクアップ化粧料の総質量を基準として、好ましくは1.0〜15.0質量%であり、より好ましくは2.0〜10.0質量%、さらにより好ましくは3.0〜6.0質量%である。含有量が1.0質量%より少ないと、肌表面に塗布した際に肌の欠点をカバーする効果を得られない場合がある。含有量が15.0質量%を超えると、含有量の増大に見合う効果が得られず、また製剤化が困難になる場合がある。 The content of the component (B) particulate metal oxide is preferably 1.0 to 15.0% by mass, more preferably 2.0 to 10.0% by mass, based on the total mass of the makeup cosmetic. %, Even more preferably 3.0 to 6.0% by mass. If the content is less than 1.0% by mass, the effect of covering the skin defects may not be obtained when applied to the skin surface. If the content exceeds 15.0% by mass, an effect commensurate with the increase in content cannot be obtained, and formulation may be difficult.
微粒子金属酸化物は、さらに、一般的な化粧料に配合される板状粉体や球状粉体にそれぞれ、又は2種類を担持して複合化等の処理を行って配合してもよい。 Further, the fine particle metal oxide may be added to a plate-like powder or a spherical powder added to a general cosmetic, respectively, or two kinds thereof may be supported and subjected to a treatment such as compounding.
本発明に係るメイクアップ化粧料は、上記必須成分(A)及び(B)の他に、さらなる粉体成分を含むことができる。 The makeup cosmetic according to the present invention can contain a further powder component in addition to the essential components (A) and (B).
例えば、成分(B)の粒径特性を満たさない酸化チタンも、隠蔽剤としての目的で、粉体成分として用いることができる。このような酸化チタンとしては、例えば、平均一次粒子径が0.2〜0.3μmである顔料級二酸化チタンを用いることができる。顔料級二酸化チタンは、高配合とすると、肌の欠点の補正力は高くなるが、可視光領域の長波長側の光の透過率が低いため、橙色〜赤色の干渉色を呈するパール顔料の反射光も遮断してしまい、本発明の効果が十分に得られない場合がある。このため、メイクアップ化粧料の総量を基準として、顔料級二酸化チタンの含有量を10.0%以下とするか、又は顔料級二酸化チタンを配合しないことが好ましい。 For example, titanium oxide that does not satisfy the particle size characteristics of component (B) can also be used as a powder component for the purpose of a masking agent. As such titanium oxide, for example, pigment grade titanium dioxide having an average primary particle diameter of 0.2 to 0.3 μm can be used. Pigment grade titanium dioxide increases the correction of skin defects when it is highly blended, but it has a low light transmittance on the long wavelength side of the visible light region, so it reflects orange to red interference colors. The light is also blocked, and the effects of the present invention may not be sufficiently obtained. For this reason, based on the total amount of makeup cosmetics, it is preferable that the content of pigment grade titanium dioxide is 10.0% or less, or pigment grade titanium dioxide is not blended.
その他の粉体成分としては、例えば、タルク、マイカ、カオリン、シリカ、セリサイト、ゼオライト、ポリエチレン粉末、ポリスチレン粉末、セルロース粉末、ナイロンパウダー、ラウロイルリジン、ポリメチルメタクリレートパウダー、窒化ホウ素、硫酸バリウム、ヒドロキシアパタイト、炭酸マグネシウム、炭酸カルシウム、珪酸マグネシウム、珪酸アルミニウム、無機白色顔料、ステアリン酸マグネシウム、ステアリン酸亜鉛、ミリスチン酸マグネシウム等の界面活性剤金属塩粉体、赤色201号、赤色202号等の有機顔料を挙げることができ、さらにこれらをシリコーン、フッ素化合物等で処理したものが好ましい。 Examples of other powder components include talc, mica, kaolin, silica, sericite, zeolite, polyethylene powder, polystyrene powder, cellulose powder, nylon powder, lauroyl lysine, polymethyl methacrylate powder, boron nitride, barium sulfate, hydroxy Apatite, magnesium carbonate, calcium carbonate, magnesium silicate, aluminum silicate, inorganic white pigment, surfactant metal salt powder such as magnesium stearate, zinc stearate, magnesium myristate, organic pigment such as red 201 and red 202 Further, those treated with silicone, fluorine compound or the like are preferable.
本発明のメイクアップ化粧料は、その他に化粧料組成物として一般に使用される水や油成分、乳化剤などを目的とする製品に応じて適宜決定される。 The makeup cosmetic composition of the present invention is appropriately determined according to other products intended for water, oil components, emulsifiers and the like generally used as cosmetic compositions.
本発明に用いる油成分は、特に制限はなく、例えば、流動パラフィン、スクワラン等の炭化水素類;オリーブ油、ホホバ油、アボカド油、ダイズ油、メドウホーム油、ラノリン等の天然動植物油脂;2−エチルヘキサン酸セチル、イソノナン酸イソノニル、イソノナン酸イソトリデシル、ミリスチン酸イソプロピル、パルミチン酸イソプロピル、パルミチン酸2−エチルヘキシル、ステアリン酸2−エチルヘキシル、ステアリン酸ステアリル等の脂肪酸エステル類;トリ(カプリル・カプリル酸)グリセリル、トリ2−エチルヘキサン酸グリセリル等のトリグリセライド、及び多価アルコール脂肪酸エステル油類;セチルアルコール、ステアリルアルコール、イソステアリルアルコール、ベヘニルアルコール等の高級アルコール;ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、イソステアリン酸等の高級脂肪酸;ジメチルポリシロキサン、メチルフェニルポリシロキサン等の鎖状シリコーン油、デカメチルシクロペンタンシロキサン等の環状シリコーン油、トリメチルシロキシケイ酸、シリコーンゲル、シリコーンパウダー等の液体又は固体のシリコーン油等が挙げられる。これら油成分を、1種又は2種以上組み合わせて使用することができる。 The oil component used in the present invention is not particularly limited. For example, hydrocarbons such as liquid paraffin and squalane; natural animal and vegetable oils and fats such as olive oil, jojoba oil, avocado oil, soybean oil, meadowweed oil and lanolin; 2-ethyl Fatty acid esters such as cetyl hexanoate, isononyl isononanoate, isotridecyl isononanoate, isopropyl myristate, isopropyl palmitate, 2-ethylhexyl palmitate, 2-ethylhexyl stearate, stearyl stearate; tri (capryl / caprylic acid) glyceryl, Triglycerides such as glyceryl tri-2-ethylhexanoate and polyhydric alcohol fatty acid ester oils; higher alcohols such as cetyl alcohol, stearyl alcohol, isostearyl alcohol, and behenyl alcohol; lauric acid Higher fatty acids such as myristic acid, palmitic acid, stearic acid, isostearic acid; chain silicone oils such as dimethylpolysiloxane and methylphenylpolysiloxane, cyclic silicone oils such as decamethylcyclopentanesiloxane, trimethylsiloxysilicic acid, silicone gel, Examples thereof include liquid such as silicone powder or solid silicone oil. These oil components can be used alone or in combination of two or more.
本発明に用いる乳化剤としては、アニオン性界面活性剤、カチオン性界面活性剤、両性界面活性剤、非イオン性界面活性剤、及びシリコーン油用の乳化剤としてシリコーン系界面活性剤等が挙げられる。成分(A)と成分(B)の分散性とメイクアップ化粧料として肌に塗布した際の感触を向上する観点から、乳化剤は、非イオン性界面活性剤、及びシリコーン系界面活性剤を用いるのが好ましく、ソルビタン脂肪酸エステル、ポリエーテル変性シリコーン、ポリグリセリン変性シリコーンを用いることがより好ましく、これらを1種以上用いることができる。 Examples of the emulsifier used in the present invention include anionic surfactants, cationic surfactants, amphoteric surfactants, nonionic surfactants, and silicone surfactants as emulsifiers for silicone oil. From the viewpoint of improving the dispersibility of component (A) and component (B) and the feel when applied to the skin as a makeup cosmetic, the emulsifier uses a nonionic surfactant and a silicone surfactant. It is more preferable to use sorbitan fatty acid ester, polyether-modified silicone, or polyglycerin-modified silicone, and one or more of these can be used.
非イオン性界面活性剤としては、モノラウリン酸ソルビタン、モノパルミチン酸ソルビタン、モノステアリン酸ソルビタン、モノオレイン酸ソルビタン、モノイソステアリン酸ソルビタン、セスキカプリル酸ソルビタン、セスキオレイン酸ソルビタン、セスキステアリン酸ソルビタン、セスキイソステアリン酸ソルビタン、トリオレイン酸ソルビタン、トリステアリン酸ソルビタン、トリイソステアリン酸ソルビタン、テトラエチルヘキサン酸ジグリセロールソルビタン、ペンタエチルヘキサン酸ジグリセロールソルビタン、ヤシ脂肪酸ソルビタン等のソルビタン脂肪酸エステル;ポリオキシエチレンヒマシ油、ポリオキシエチレン硬化ヒマシ油及びこれらの誘導体;モノラウリン酸ポリオキシエチレンソルビット、テトラステアリン酸ポリオキシエチレンソルビット脂肪酸エステル;モノステアリン酸グリセリル、自己乳化型モノステアリン酸グリセリル、モノイソステアリン酸グリセリル等のグリセリン脂肪酸エステル;モノステアリン酸ポリオキシエチレングリセリル、モノイソステアリン酸ポリオキシエチレングリセリル、トリステアリン酸ポリオキシエチレングリセリル、トリイソステアリン酸ポリオキシエチレングリセリル、トリオレイン酸ポリオキシエチレングリセリル等のポリオキシエチレングリセリン脂肪酸エステル;ポリオキシエチレンラウリルエーテル、ポリオキシエチレンセチルエーテル、ポリオキシエチレンステアリルエーテル、ポリオキシエチレンオレイルエーテル、ポリオキシエチレンオクチルドデシルエーテル等のポリオキシエチレンアルキルエーテル;モノラウリン酸ポリエチレングリコール、モノオレイン酸ポリエチレングリコール等のポリエチレングリコール脂肪酸エステル;モノラウリン酸ポリグリセリル、モノミリスチン酸ポリグリセリル、モノステアリン酸ポリグリセリル、モノオレイン酸ポリグリセリル、トリステアリン酸ポリグリセリル、トリオレイン酸ポリグリセリル等のポリグリセリン脂肪酸エステル等が挙げられる。 Nonionic surfactants include sorbitan monolaurate, sorbitan monopalmitate, sorbitan monostearate, sorbitan monooleate, sorbitan monoisostearate, sorbitan sesquicaprylate, sorbitan sesquioleate, sorbitan sesquistearate, sesquiisostearate Sorbitan fatty acid esters such as sorbitan acid, sorbitan trioleate, sorbitan tristearate, sorbitan triisostearate, diglycerol sorbitan tetraethylhexanoate, diglycerol sorbitan pentaethylhexanoate, coconut fatty acid sorbitan; polyoxyethylene castor oil, polyoxyethylene Ethylene hydrogenated castor oil and derivatives thereof; polyoxyethylene sorbite monolaurate, polytetrastearate Xylethylene sorbite fatty acid ester; glyceryl fatty acid ester such as glyceryl monostearate, glyceryl monostearate, glyceryl monoisostearate; polyoxyethylene glyceryl monostearate, polyoxyethylene glyceryl monoisostearate, polyoxytristearate Polyoxyethylene glycerin fatty acid esters such as ethylene glyceryl, polyoxyethylene glyceryl triisostearate, polyoxyethylene glyceryl trioleate; polyoxyethylene lauryl ether, polyoxyethylene cetyl ether, polyoxyethylene stearyl ether, polyoxyethylene oleyl ether Polyoxyethylene alkyl ethers such as polyoxyethylene octyldodecyl ether Ter; polyethylene glycol fatty acid esters such as polyethylene glycol monolaurate, polyethylene glycol monooleate; polyglyceryl monolaurate, polyglyceryl monomyristate, polyglyceryl monostearate, polyglyceryl monooleate, polyglyceryl tristearate, polyglyceryl tristearate, etc. Examples include glycerin fatty acid esters.
ポリエーテル変性シリコーンとしては、PEG−3ジメチコン、PEG−9メチルエーテルジメチコン、PEG−10ジメチコン、PEG−10メチルエーテルジメチコン、PEG−12ジメチコン、PEG−32メチルエーテルジメチコン、PEG−9ポリジメチルシロキシエチルジメチコン、PEG/PPG−19/19ジメチコン、ポリシリコーン−13、ラウリルPEG−9ポリジメチルシロキシエチルジメチコン、ラウリルPEG−10トリス(トリメチルシロキシ)シリルエチルジメチコン等が挙げられる。 Polyether-modified silicones include PEG-3 dimethicone, PEG-9 methyl ether dimethicone, PEG-10 dimethicone, PEG-10 methyl ether dimethicone, PEG-12 dimethicone, PEG-32 methyl ether dimethicone, PEG-9 polydimethylsiloxyethyl. Examples include dimethicone, PEG / PPG-19 / 19 dimethicone, polysilicone-13, lauryl PEG-9 polydimethylsiloxyethyl dimethicone, lauryl PEG-10 tris (trimethylsiloxy) silylethyl dimethicone, and the like.
ポリグリセリン変性シリコーンとしては、ポリグリセリル−3ジシロキサンジメチコン、ポリグリセリル−3ポリジメチルシロキシエチルジメチコン、ラウリルポリグリセリル−3ポリジメチルシロキシエチルジメチコン等を挙げることができる。 Examples of the polyglycerin-modified silicone include polyglyceryl-3 disiloxane dimethicone, polyglyceryl-3 polydimethylsiloxyethyl dimethicone, and lauryl polyglyceryl-3 polydimethylsiloxyethyl dimethicone.
本発明のメイクアップ化粧料には、多価アルコール、保湿剤、糖類、防腐剤、抗菌剤、金属イオン封鎖剤、水溶性高分子のような高分子増粘剤、低級アルコール、皮膜形成剤、中和剤、pH調整剤、粉体成分、紫外線吸収剤等を含有させることができる。また、ビタミン類、皮膚賦活剤、血行促進剤、抗炎症剤、美白剤等の他の化粧成分や薬効成分、生理活性成分、香料、色素を含有させることもできる。 The makeup cosmetics of the present invention include polyhydric alcohols, humectants, sugars, preservatives, antibacterial agents, sequestering agents, polymer thickeners such as water-soluble polymers, lower alcohols, film forming agents, A neutralizer, a pH adjuster, a powder component, an ultraviolet absorber and the like can be contained. In addition, vitamins, skin activators, blood circulation promoters, anti-inflammatory agents, whitening agents and other cosmetic ingredients, medicinal ingredients, physiologically active ingredients, fragrances, and pigments can also be included.
多価アルコールとしては、特に限定されず、化粧料組成物として一般に使用されているものを使用することができる。例えば、1,3−ブチレングリコール、ジプロピレングリコール、プロピレングリコール、グリセリン、1,2−ペンタンジオール、イソプレングリコール、ポリエチレングリコール、メチルグルコシド、ソルビトール、ジグリセリン等が挙げられる。 The polyhydric alcohol is not particularly limited, and those generally used as cosmetic compositions can be used. Examples include 1,3-butylene glycol, dipropylene glycol, propylene glycol, glycerin, 1,2-pentanediol, isoprene glycol, polyethylene glycol, methyl glucoside, sorbitol, diglycerin and the like.
保湿剤及び糖類としては、例えば、ヒアルロン酸、コラーゲン、エラスチン、乳酸ナトリウム、シクロデキストリン、ピロリドンカルボン酸及びその塩、天然及び合成のセラミド類等が挙げられる。 Examples of the humectant and saccharide include hyaluronic acid, collagen, elastin, sodium lactate, cyclodextrin, pyrrolidone carboxylic acid and salts thereof, natural and synthetic ceramides, and the like.
防腐剤及び抗菌剤としては、例えば、安息香酸、サリチル酸、石炭酸、ソルビン酸、パラオキシ安息香酸エステル、パラクロルメタクレゾール、ヘキサクロロフェン、塩化ベンザルコニウム、塩化クロルヘキシジン、トリクロロカルバニリド、感光素、フェノキシエタノール等が挙げられる。 Examples of antiseptics and antibacterial agents include benzoic acid, salicylic acid, coalic acid, sorbic acid, p-oxybenzoic acid ester, parachloromethcresol, hexachlorophene, benzalkonium chloride, chlorhexidine chloride, trichlorocarbanilide, photosensitizer, phenoxyethanol Etc.
金属イオン封鎖剤としては、例えば、エチレンジアミン四酢酸二ナトリウム、エデト酸、エデト酸ナトリウム塩等のエデト酸塩を挙げることができる。 Examples of the sequestering agent include edetate salts such as disodium ethylenediaminetetraacetate, edetic acid, and sodium edetate.
水溶性高分子あるいは増粘剤としては、例えば、アラビアゴム、トラガカントガム、ガラクタン、グアーガム、カラギーナン、ペクチン、寒天、クインスシード、デキストラン、デキストリン、プルラン、カルボキシメチルデンプン、コラーゲン、カゼイン、ゼラチン、メチルセルロース、メチルヒドロキシプロピルセルロース、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、カルボキシメチルセルロースナトリウム、アルギン酸ナトリウム、カルボキシメチルデキストランナトリウム、カルボキシビニルポリマー、ベントナイト等を挙げることができる。 Examples of the water-soluble polymer or thickener include gum arabic, gum tragacanth, galactan, guar gum, carrageenan, pectin, agar, quince seed, dextran, dextrin, pullulan, carboxymethyl starch, collagen, casein, gelatin, methylcellulose, methyl Examples thereof include hydroxypropylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, sodium carboxymethylcellulose, sodium alginate, carboxymethyldextran sodium, carboxyvinyl polymer, bentonite and the like.
低級アルコールとしては、エタノール、イソプロパノールが挙げられる。 Examples of lower alcohols include ethanol and isopropanol.
皮膜形成剤としては、トリメチルシロキシケイ酸、ポリプロピルシルセスキオキサン、ポリアクリル酸アルキル、エイコセン・ビニルピロリドン重合体、エステルガム等が挙げられる。 Examples of the film forming agent include trimethylsiloxysilicic acid, polypropylsilsesquioxane, polyalkyl acrylate, eicosene vinylpyrrolidone polymer, ester gum and the like.
中和剤としては、例えば、水酸化カリウム、水酸化ナトリウム、トリエタノールアミン、炭酸ナトリウム等が挙げられる。 Examples of the neutralizing agent include potassium hydroxide, sodium hydroxide, triethanolamine, sodium carbonate and the like.
pH調整剤としては、乳酸、クエン酸、グリコール酸、コハク酸、酒石酸、dl−リンゴ酸、炭酸カリウム、炭酸水素ナトリウム、炭酸水素アンモニウム等が挙げられる。 Examples of the pH adjuster include lactic acid, citric acid, glycolic acid, succinic acid, tartaric acid, dl-malic acid, potassium carbonate, sodium hydrogen carbonate, ammonium hydrogen carbonate and the like.
紫外線吸収剤としては、パラメトキシケイ皮酸2−エチルヘキシル、2−(4−ジエチルアミノ−2−ヒドロキシベンゾイル)安息香酸ヘキシルエステル、パラメトキシケイ皮酸ベンジル、パラメトキシケイ皮酸2−エチルヘキシル、パラメトキシケイ皮酸2−エトキシエチル、ジパラメトキシケイ皮酸モノ−2−エチルヘキサン酸グリセリル、パラメトキシケイ皮酸イソプロピル・ジイソプロピルケイ皮酸エステル混合物等のケイ皮酸系紫外線吸収剤、ヒドロキシメトキシベンゾフェノン、ヒドロキシメトキシベンゾフェノンスルホン酸、ヒドロキシメトキシベンゾフェノンスルホン酸ナトリウム、ジヒドロキシメトキシベンゾフェノン、ジヒドロキシメトキシベンゾフェノンジスルホン酸ナトリウム、ジヒドロキシベンゾフェノン、テトラヒドロキシベンゾフェノン等のベンゾフェノン系紫外線吸収剤、パラアミノ安息香酸、パラアミノ安息香酸エチル、パラアミノ安息香酸グリセリル、パラジメチルアミノ安息香酸アミル、パラジメチルアミノ安息香酸オクチル、4−[N,N−ジ(2−ヒドロキシプロピル)アミノ]安息香酸エチル、2−(4―ジエチルアミノ−2−ヒドロキシベンゾイル)−安息香酸ヘキシルエステル等の安息香酸エステル系紫外線吸収剤、サリチル酸エチレングリコール、サリチル酸フェニル、サリチル酸オクチル、サリチル酸ベンジル、サリチル酸p−tert−ブチルフェニル、サリチル酸ホモメンチル等のサリチル酸系紫外線吸収剤、2,4,6−トリアニリノ−p−(カルボ−2’−エチルヘキシル−1’−オキシ)−1,3,5−トリアジン等のトリアジン系紫外線吸収剤、4−tert−ブチル−4’−メトキシジベンゾイルメタン、オキシベンゾン、オクトクリレン、アントラニル酸メンチル、2−(2−ヒドロキシ−5−メチルフェニル)ベンゾトリアゾール、ジメトキシベンジリデンジオキソイミダゾリジンプロピオン酸2−エチルヘキシル、2−フェニルベンズイミダゾール−5−スルホン酸、2−シアノ−3,3−ジフェニルアクリレート等を用いることができる。 Examples of the UV absorber include 2-methoxyhexyl paramethoxycinnamate, 2- (4-diethylamino-2-hydroxybenzoyl) benzoic acid hexyl ester, benzyl paramethoxycinnamate, 2-ethylhexyl paramethoxycinnamate, paramethoxy Cinnamic acid UV absorbers such as 2-ethoxyethyl cinnamate, glyceryl mono-2-ethylhexanoate diparamethoxycinnamate, isopropyl dimethoxycinnamate and diisopropyl cinnamate ester, hydroxymethoxybenzophenone, Hydroxymethoxybenzophenone sulfonic acid, sodium hydroxymethoxybenzophenone sulfonate, dihydroxymethoxybenzophenone, dihydroxymethoxybenzophenone sodium disulfonate, dihydroxybenzophenone, tet Benzophenone ultraviolet absorbers such as hydroxybenzophenone, paraaminobenzoic acid, ethyl paraaminobenzoate, glyceryl paraaminobenzoate, amyl paradimethylaminobenzoate, octyl paradimethylaminobenzoate, 4- [N, N-di (2-hydroxy) Propyl) amino] ethyl benzoate, benzoic acid ester UV absorbers such as 2- (4-diethylamino-2-hydroxybenzoyl) -benzoic acid hexyl ester, ethylene glycol salicylate, phenyl salicylate, octyl salicylate, benzyl salicylate, p-salicylate p -Salicylic acid ultraviolet absorbers such as tert-butylphenyl and homomenthyl salicylate, 2,4,6-trianilino-p- (carbo-2'-ethylhexyl-1'-oxy) -1,3,5-triazi Triazine-based ultraviolet absorbers such as 4-tert-butyl-4′-methoxydibenzoylmethane, oxybenzone, octocrylene, menthyl anthranilate, 2- (2-hydroxy-5-methylphenyl) benzotriazole, dimethoxybenzylidene dioxoimidazo Lysine propionate 2-ethylhexyl, 2-phenylbenzimidazole-5-sulfonic acid, 2-cyano-3,3-diphenyl acrylate and the like can be used.
薬効成分としては、例えば、コエンザイムQ10、ビタミンA油、レチノール等のビタミンA類、リボフラビン等のビタミンB2類、ピリドキシン塩酸塩等のB6類、L−アスコルビン酸、L−アスコルビン酸リン酸マグネシウム、L−アスコルビン酸モノパルミチン酸エステル、L−アスコルビン酸ジパルミチン酸エステル、L−アスコルビン酸−2−グルコシド等のビタミンC類、パントテン酸カルシウム等のパントテン酸類、ビタミンD2、コレカルシフェロール等のビタミンD類;α−トコフェロール、酢酸トコフェロール、ニコチン酸DL−α−トコフェロール等のビタミンE類等のビタミン類を挙げることができる。アルブチン、エラグ酸、トラネキサム酸、プラセンタエキス、グルタチオン、ユキノシタ抽出物等の美白剤、ローヤルゼリー、ブナノキエキス等の皮膚賦活剤、カプサイシン、ジンゲロン、カンタリスチンキ、イクタモール、カフェイン、タンニン酸、γ−オリザノール等の血行促進剤、グリチルリチン酸誘導体、グリチルレチン酸誘導体、アズレン、アライトイン等の消炎剤、アルギニン、セリン、ロイシン、トリプトファン等のアミノ酸類等を挙げることができる。さらに、セイヨウトチノキ種子エキス、カミツレ花エキス、ソウハクヒエキス、ボタンエキス、パセリエキス、ブナノキエキス、ワイン酵母エキス、グレープフルーツエキス、スイカズラエキス、コメエキス、ブドウエキス、ホップエキス、コメヌカエキス、ビワエキス、オウバクエキス、ヨクイニンエキス、センブリエキス、メリロートエキス、バーチエキス、カンゾウエキス、シャクヤクエキス、サボンソウエキス、ヘチマエキス、トウガラシエキス、レモンエキス、ゲンチアナエキス、シソエキス、アロエエキス、ローズマリーエキス、セージエキス、ケイヒエキス、タイムエキス、茶エキス、海藻エキス、キューカンバーエキス、チョウジエキス、ニンジンエキス、マロニエエキス、ハマメリスエキス、クワエキス、オウゴンエキス、オトギリソウエキス、セイヨウサンザシエキス、ツボクサエキス、クズ根粒エキス、アーティチョーク葉エキス、エイジツエキス、エーデルワイスエキス等の各種抽出物を挙げることができる。 The medicinal ingredient, for example, coenzyme Q10, vitamin A oil, vitamin A such as retinol, vitamin B 2 such as riboflavin, B 6 such as pyridoxine hydrochloride, L- ascorbic acid, L- ascorbic acid magnesium phosphate Vitamin C such as L-ascorbic acid monopalmitate, L-ascorbic acid dipalmitate, L-ascorbic acid-2-glucoside, pantothenic acids such as calcium pantothenate, vitamin D 2 , cholecalciferol, etc. Vitamin Ds: Vitamins such as vitamin E such as α-tocopherol, tocopherol acetate, and DL-α-tocopherol nicotinate. Whitening agents such as arbutin, ellagic acid, tranexamic acid, placenta extract, glutathione, and yukinoshita extract, skin activators such as royal jelly, beech extract, capsaicin, gingeron, cantalis tincture, ictamol, caffeine, tannic acid, γ-oryzanol And the like, glycyrrhizic acid derivatives, glycyrrhetinic acid derivatives, anti-inflammatory agents such as azulene and allitein, and amino acids such as arginine, serine, leucine and tryptophan. In addition, horse chestnut seed extract, chamomile flower extract, Sakuhakhi extract, button extract, parsley extract, beech extract, wine yeast extract, grapefruit extract, honeysuckle extract, rice extract, grape extract, hop extract, rice bran extract, loquat extract, agaric extract, yokuinin extract , Assembly extract, merirot extract, birch extract, licorice extract, peony extract, bonito extract, loofah extract, red pepper extract, lemon extract, gentian extract, perilla extract, aloe extract, rosemary extract, sage extract, cinnamon extract, thyme extract, Tea extract, seaweed extract, cucumber extract, clove extract, carrot extract, maronnier extract, hamamelis extract, mulberry extract, ougon extract Hypericum extract, hawthorn extract, Centella asiatica extract, kudzu root nodule extract, artichoke leaf extract, rose fruit extract, may be mentioned various extracts such as Edelweiss extract.
香料としては、公知の合成香料、動物性香料、天然精油、合成製油等が挙げられる。 Examples of the fragrances include known synthetic fragrances, animal fragrances, natural essential oils, and synthetic oil refineries.
本発明に係るメイクアップ化粧料の用途は、特に限定されないが、ファンデーション、化粧下地、コンシーラー、頬紅、口紅等の他に、日焼け止め化粧料においても発明の効果を発揮しやすく、好適に用いることができる。例えば、ファンデーションの剤型は、例えば、ルース状ファンデーション(白粉)、ケーキ状のパウダーファンデーション、W/O乳化リキッドファンデーション、油性スティックファンデーション等であってよく、また、化粧下地は、W/O乳化化粧下地やO/W乳化化粧下地であってよく、任意の剤型において、隠蔽効果と肌の透明感を両立させる効果を与える。中でも、本発明に係るメイクアップ化粧料の特に好ましい剤型としては、乳化化粧料が挙げられる。 The use of the makeup cosmetic according to the present invention is not particularly limited, but in addition to foundations, makeup bases, concealers, blushers, lipsticks, etc., it is easy to exert the effects of the invention in sunscreen cosmetics and should be used suitably. Can do. For example, the dosage form of the foundation may be, for example, a loose foundation (white powder), a cake-like powder foundation, a W / O emulsified liquid foundation, an oily stick foundation, or the like, and the makeup base is a W / O emulsified makeup. It may be a base or an O / W emulsified makeup base, and in any dosage form, it provides an effect of achieving both a concealing effect and a skin transparency. Especially, emulsified cosmetics are mentioned as a particularly preferable dosage form of the makeup cosmetics according to the present invention.
本発明に係るメイクアップ化粧料は、メイクアップ化粧料に通常配合される成分と上記成分とを混合し、それらの製造方法は、特に限定されるものではなく、常法により調製される。 The makeup cosmetic according to the present invention is prepared by mixing a component usually mixed in a makeup cosmetic with the above components, and the production method thereof is not particularly limited, and is prepared by a conventional method.
例えば、メイクアップ化粧料が油中水型乳化ファンデーションである場合、まずは、油相を形成する。例えば、2種以上の油成分と2種以上の乳化剤とを混合した後に、70〜80℃に加熱した状態で、撹拌(例えば1000〜2000回転/分、5〜10分間)することで、均一な油相を形成することができる。油成分と乳化剤は、各々上述した成分から少なくとも2種以上を選択することができる。油成分と乳化剤の他に、混合時において、皮膜形成剤、紫外線吸収剤、薬効成分を加えてもよい。次に、水相を形成する。例えば、水と2種以上の多価アルコールと防腐剤又は抗菌剤とを混合した後に、70〜80℃で加熱することで、水に他の成分が溶解した水相を形成することができる。多価アルコールと防腐剤又は抗菌剤は、各々上述した成分から選択することができる。水と多価アルコールと防腐剤又は抗菌剤の他に、混合時において、保湿剤、糖類、金属イオン封鎖剤、水溶性高分子のような高分子増粘剤、低級アルコール、皮膜形成剤、中和剤、pH調整剤、薬効成分を加えてもよい。次に、成分(A)と成分(B)とを少なくとも含む粉体混合物を得る。例えば、成分(A)と成分(B)と2種以上の粉体成分とを混合して、例えばヘンシェルミキサーで均一分散させた混合物を得る。成分(A)と成分(B)の他に、顔料級二酸化チタンや、その他の2種以上の粉体成分を加えてもよい。次に、粉体混合物を油相に加える。例えば、上述した粉体混合物を油相へ加えて、撹拌(例えば3000〜4000回転/分、5〜10分間)することで、粉末が均一に分散した油相を得ることができる。次に、粉末を含有した油相に水相を添加する。例えば、上述した粉末が均一に分散した油相に、撹拌(例えば3000〜4000回転/分)した状態で、ゆっくりと少量ずつ水相を添加してもよい。次に、粉末を含有した油相と水相の混合物を加熱した状態で撹拌する。例えば、上述した粉末を含有した油相と水相の混合物を、70〜80℃に加熱した状態で、ホモミキサーを用いて高速撹拌(例えば5000〜6000回転/分、5〜10分)することで、乳化物を得てもよい。次に、乳化物を冷却する。例えば、氷や冷水を用いて、乳化物が20〜30℃になるまで冷却してもよい。次に、冷却した乳化物を脱気する。例えば、真空ポンプを用いて脱気させてもよい。脱気後の乳化物は、油中水型乳化ファンデーションである。最後に、脱気した乳化物を容器に充填してもよい。 For example, when the makeup cosmetic is a water-in-oil type emulsion foundation, first, an oil phase is formed. For example, after mixing two or more kinds of oil components and two or more kinds of emulsifiers, in a state heated to 70 to 80 ° C., stirring (for example, 1000 to 2000 rotations / minute, 5 to 10 minutes) is performed uniformly. An oil phase can be formed. The oil component and the emulsifier can each be selected from at least two or more of the components described above. In addition to the oil component and the emulsifier, a film forming agent, an ultraviolet absorber, and a medicinal component may be added during mixing. Next, an aqueous phase is formed. For example, after mixing water, 2 or more types of polyhydric alcohol, antiseptic | preservative, or an antibacterial agent, the water phase which the other component melt | dissolved in water can be formed by heating at 70-80 degreeC. The polyhydric alcohol and the preservative or antibacterial agent can each be selected from the components described above. In addition to water, polyhydric alcohol and antiseptic or antibacterial agent, when mixed, moisturizer, sugar, sequestering agent, polymer thickener such as water-soluble polymer, lower alcohol, film forming agent, medium You may add a summing agent, a pH adjuster, and a medicinal component. Next, a powder mixture containing at least the component (A) and the component (B) is obtained. For example, the component (A), the component (B), and two or more powder components are mixed and a mixture that is uniformly dispersed by, for example, a Henschel mixer is obtained. In addition to component (A) and component (B), pigment grade titanium dioxide or other two or more powder components may be added. Next, the powder mixture is added to the oil phase. For example, by adding the powder mixture described above to the oil phase and stirring (for example, 3000 to 4000 rotations / minute, 5 to 10 minutes), an oil phase in which the powder is uniformly dispersed can be obtained. Next, the water phase is added to the oil phase containing the powder. For example, the aqueous phase may be slowly added little by little to the oil phase in which the above-mentioned powder is uniformly dispersed while stirring (for example, 3000 to 4000 rpm). Next, the mixture of the oil phase and the aqueous phase containing the powder is stirred in a heated state. For example, the mixture of the oil phase and the aqueous phase containing the powder described above is heated at 70 to 80 ° C. and stirred at high speed (for example, 5000 to 6000 rpm / minute, 5 to 10 minutes) using a homomixer. Thus, an emulsion may be obtained. Next, the emulsion is cooled. For example, the emulsion may be cooled to 20 to 30 ° C. using ice or cold water. Next, the cooled emulsion is degassed. For example, you may deaerate using a vacuum pump. The emulsion after deaeration is a water-in-oil emulsion foundation. Finally, the degassed emulsion may be filled into a container.
メイクアップ化粧料が水中油型乳化化粧下地又は油中水型乳化コンシーラーである場合も、上述した油中水型乳化ファンデーションと同様の手法によって製造してもよい。 Even when the makeup cosmetic is an oil-in-water emulsified cosmetic base or a water-in-oil emulsified concealer, it may be produced by the same method as the water-in-oil emulsified foundation described above.
メイクアップ化粧料がケーキ状パウダーファンデーションである場合、水相を形成せずに、油相を粉体混合物に加え、例えばヘルシェルミキサーで撹拌(例えば100〜200回転/分、1〜10分間)して、粉末を均一に分散する。油相を混合した後の粉末混合物を篩、例えば60メッシュの篩に通す。篩を通過した粉末は、パウダーファンデーションとして用いることができる。篩を通過した粉末を金皿に充填し圧縮成形して、ケーキ状パウダーファンデーションとしてもよい。 When the makeup cosmetic is a cake-like powder foundation, the oil phase is added to the powder mixture without forming an aqueous phase, and stirred with, for example, a Hellshell mixer (for example, 100 to 200 revolutions / minute, 1 to 10 minutes) Then, the powder is uniformly dispersed. The powder mixture after mixing the oil phase is passed through a sieve, for example a 60 mesh sieve. The powder that has passed through the sieve can be used as a powder foundation. The powder that has passed through the sieve may be filled into a metal pan and compression molded to form a cake-like powder foundation.
また、メイクアップ化粧料が油性スティック状ファンデーションである場合、水相を形成せずに、粉体混合物を油相に加えて、例えばディスパー攪拌機を用いて、撹拌(例えば3000〜4000回転/分、5〜10分間)して、粉末が均一に分散した油相を得た後に、金型に充填して0〜20℃となるように冷却し、容器に装填して油性スティック状ファンデーションとしてもよい。 In addition, when the makeup cosmetic is an oily stick foundation, the powder mixture is added to the oil phase without forming an aqueous phase, and stirred using, for example, a disper stirrer (for example, 3000 to 4000 rpm). 5 to 10 minutes) to obtain an oil phase in which the powder is uniformly dispersed, and then filled in a mold, cooled to 0 to 20 ° C., and loaded into a container to form an oily stick foundation. .
次に,実施例及び比較例を挙げて本発明をさらに具体的に説明するが、本発明に係るメイクアップ化粧料はこれらの実施例によって限定されるものではない。 Next, the present invention will be described more specifically with reference to examples and comparative examples, but the makeup cosmetics according to the present invention are not limited to these examples.
[実施例1〜5、比較例1〜6:油中水型乳化ファンデーションの調製]
下記表1及び表2に示す組成の油中水型乳化ファンデーションを、次の方法で調製した。
まず、成分(1)〜(8)を混合し、80℃に加熱した状態で、ディスパー撹拌機を用いて1000回転/分で5分間撹拌して、均一な油相とした。次に、成分(9)〜(15)を混合し、80℃まで加熱することで加熱溶解させて、水相とした。次に、成分(16)〜(30)を混合し、ヘンシェルミキサー(三井鉱山社製FM−10)で均一に分散させた。その後に、油相へ加え、ディスパー撹拌機を用いて3000回転/分で10分間撹拌して、均一に混合した。次に、この粉末を含有した油相に、撹拌した状態でゆっくりと水相を添加した。次に、水相を添加した粉末含有油相を、80℃に加熱した状態で、ホモミキサーを用いて高速撹拌(5000rpm、5分間)して乳化混合させた。次に、この乳化混合物を氷と冷水を用いて30℃になるまで冷却をした後に、真空ポンプを用いて脱気させ、容器に充填をして油中水型乳化ファンデーションを得た。
[Examples 1 to 5, Comparative Examples 1 to 6: Preparation of water-in-oil type emulsion foundation]
Water-in-oil emulsion foundations having the compositions shown in Tables 1 and 2 below were prepared by the following method.
First, components (1) to (8) were mixed and stirred at 1000 rpm for 5 minutes using a disper stirrer while heating to 80 ° C. to obtain a uniform oil phase. Next, components (9) to (15) were mixed and heated to 80 ° C. to be dissolved by heating to obtain an aqueous phase. Next, the components (16) to (30) were mixed and dispersed uniformly using a Henschel mixer (FM-10 manufactured by Mitsui Mining Co., Ltd.). Thereafter, the mixture was added to the oil phase and stirred for 10 minutes at 3000 rpm using a disper stirrer and mixed uniformly. Next, the aqueous phase was slowly added to the oil phase containing the powder while stirring. Next, the powder-containing oil phase to which the aqueous phase was added was emulsified and mixed by high-speed stirring (5000 rpm, 5 minutes) using a homomixer while being heated to 80 ° C. Next, this emulsified mixture was cooled to 30 ° C. using ice and cold water, then degassed using a vacuum pump, and filled into a container to obtain a water-in-oil emulsified foundation.
実施例1〜5及び比較例1〜6の油中水型乳化ファンデーションを、化粧用スポンジを用いて、女性被験者(30〜50歳)の顔に塗布し、塗布時の仕上がりを自己評価した。 The water-in-oil type emulsion foundations of Examples 1 to 5 and Comparative Examples 1 to 6 were applied to the face of a female subject (30 to 50 years old) using a cosmetic sponge, and the finish at the time of application was self-evaluated.
[評価方法]
3項目「シミや毛穴を隠している」、「透明感があり自然な仕上がりである」、「化粧効果の持続性」の其々の項目について、各自が以下の評価基準に従って5段階評価し、5名の平均点を以下の判定基準に従って判定した。なお、化粧効果の持続性は、塗布してから6時間後において、シミや毛穴が隠れているか又は透明感があるかの点で評価した。
[Evaluation method]
For each of the three items “hidden spots and pores”, “transparent and natural finish”, and “continuity of makeup effect”, each of them is evaluated in five levels according to the following evaluation criteria, The average score of 5 people was determined according to the following criteria. In addition, the sustainability of the makeup effect was evaluated in terms of whether spots or pores were hidden or transparent after 6 hours from application.
評価基準:
[評価結果] : [評点]
非常に良好 : 5点
良好 : 4点
ふつう : 3点
やや不良 : 2点
不良 : 1点
判断基準:
[評点平均点] : [判定]
4.5以上 : ◎
3.5以上〜4.5未満 : ○
1.5以上〜3.5未満 : △
1.5未満 : ×
Evaluation criteria:
[Evaluation result]: [Grade]
Very good: 5 points Good: 4 points Normal: 3 points Somewhat bad: 2 points Bad: 1 point Criteria:
[Grade average]: [Judgment]
4.5 or more: ◎
3.5 or more and less than 4.5: ○
1.5 or more and less than 3.5: △
Less than 1.5: ×
*1:KF−7312J(信越化学工業社製)
*2:KSG−16(信越化学工業社製)
*3:MPY−1133M(テイカ社製 ジメチコン処理粉体 平均粒子径0.25μm)
*4:MT−700Z(テイカ社製 ステアリン酸処理粉体 平均粒子径0.08μm)
*5:MZY−203S(テイカ社製 ハイドロゲンジメチコン処理粉体 平均粒子径0.05μm)
*6:TTO−S−4(石原産業社製 ステアリン酸処理粉体 平均粒子径0.015μm)
*7:MZY−505S(テイカ社製 ハイドロゲンジメチコン処理粉体 平均粒子径0.025μm)
*8:デュオクロムRY(BASF社製 カルミン被覆雲母チタン 平均粒子径25μm)
なお、上記のA成分であるシリコーン処理フラメンコシルクレッド及びシリコーン処理フラメンコシルクオレンジ、並びに、A成分の比較品であるシリコーン処理フラメンコシルクバイオレットは、いずれもBASF社製のパール顔料にシリコーン処理を施したものである。シリコーン処理は、以下のように行った。まず、パール顔料490gとメチルハイドロジェンポリシロキサン(商品名:KF−9901:信越化学工業社製)10gをイソプロパノール50mlに溶かした後に、ヘンシェルミキサーに入れ、室温で撹拌して混合物を得た。次に、この混合物を100℃の乾燥機中に入れて溶媒を蒸発させて粉末化した。次に、得られた粉末を、予め400℃に設定した電気炉内に入れて3時間加熱を行い、シリコーン処理粉末を得た。
* 1: KF-7312J (manufactured by Shin-Etsu Chemical Co., Ltd.)
* 2: KSG-16 (manufactured by Shin-Etsu Chemical Co., Ltd.)
* 3: MPY-1133M (Taika's dimethicone-treated powder average particle size 0.25 μm)
* 4: MT-700Z (manufactured by Teika, stearic acid-treated powder, average particle size: 0.08 μm)
* 5: MZY-203S (Hydrogen dimethicone-treated powder, average particle size 0.05 μm, manufactured by Teica)
* 6: TTO-S-4 (Ishihara Sangyo Co., Ltd., stearic acid-treated powder, average particle size: 0.015 μm)
* 7: MZY-505S (manufactured by Teika Co., Ltd., hydrogen dimethicone-treated powder, average particle size: 0.025 μm)
* 8: Duochrome RY (BASF Carmine-coated mica titanium
In addition, the silicone-treated flamenco silk red and silicone-treated flamenco silk orange, which are the above-mentioned A component, and the silicone-treated flamenco silk violet, which is a comparative product of the A component, were all subjected to silicone treatment on a pearl pigment manufactured by BASF. Is. Silicone treatment was performed as follows. First, 490 g of pearl pigment and 10 g of methyl hydrogen polysiloxane (trade name: KF-9901: manufactured by Shin-Etsu Chemical Co., Ltd.) were dissolved in 50 ml of isopropanol, then placed in a Henschel mixer and stirred at room temperature to obtain a mixture. Next, this mixture was put in a dryer at 100 ° C. to evaporate the solvent and powdered. Next, the obtained powder was put in an electric furnace previously set at 400 ° C. and heated for 3 hours to obtain a silicone-treated powder.
表1及び表2の結果から、本発明のメイクアップ化粧料である実施例1〜5の油中水型乳化ファンデーションは、「シミや毛穴を隠している」、「透明感があり自然な仕上がりである」、「化粧効果の持続性」の全ての項目に優れたメイクアップ化粧料であった。 From the results of Tables 1 and 2, the water-in-oil type emulsified foundations of Examples 1 to 5 which are the makeup cosmetics of the present invention are "hidden spots and pores", "transparent and natural finish" It was a makeup cosmetic that was excellent in all items of “It is” and “Durability of makeup effect”.
一方、成分(A)を含まない比較例1又は成分(A)の比較品を用いた比較例2及び3は、シミや毛穴を隠す効果は十分でなく、透明感があり自然な仕上がりは得られなかった。さらに、成分(B)を含まない比較例4又は成分(B)の比較品を用いた比較例5及び6は、シミや毛穴を隠す効果は十分でなかった。そして、比較例1〜6の全てにおいて、化粧効果の持続性は、十分ではなかった。 On the other hand, Comparative Example 2 and 3 using Comparative Example 1 that does not contain Component (A) or Comparative Product of Component (A) are not sufficient in hiding spots and pores, and have a clear and natural finish. I couldn't. Furthermore, the comparative example 4 which does not contain a component (B) or the comparative examples 5 and 6 using the comparative product of a component (B) were not enough in the effect which hides a spot and a pore. And in all of Comparative Examples 1-6, the sustainability of the makeup effect was not sufficient.
[分光反射率の評価]
次に、実施例1〜5及び比較例1〜6のメイクアップ化粧料を、各々黒色人工皮革上に1mg/cm2となるように塗布し、分光測定用のサンプルを作製した。このサンプルを用いて、分光測色計(日本電色工業社製、型番SD5000)を用いて、可視光線領域内(400nm〜700nm)における反射率を測定した。実施例1〜5の結果を図1に示し、実施例1及び比較例1〜6の結果を図2に示す。実施例1〜5は、いずれも長波長側(580nm〜700nm)において反射率が高かったことから、肌色の補正効果が十分に得られたと考える。実施例1は、比較例1及び比較例3〜6と比べて、測定した波長領域内において反射率が高く、波長580〜700nmにおいて特に反射率が高かった。このことから、肌色の補正効果が十分に得られたと考える。比較例2は、成分(A)として赤色の色素被覆パール顔料を用いているため、長波長側での反射率は高かったが、長波長以外の波長領域においては実施例1よりも反射率が低く、また、上述したように化粧効果の持続性が不十分であった。
[Evaluation of spectral reflectance]
Next, the makeup cosmetics of Examples 1 to 5 and Comparative Examples 1 to 6 were each applied onto black artificial leather so as to have a concentration of 1 mg / cm 2 to prepare spectroscopic measurement samples. Using this sample, the reflectance in the visible light region (400 nm to 700 nm) was measured using a spectrocolorimeter (manufactured by Nippon Denshoku Industries Co., Ltd., model number SD5000). The result of Examples 1-5 is shown in FIG. 1, and the result of Example 1 and Comparative Examples 1-6 is shown in FIG. In all of Examples 1 to 5, since the reflectance was high on the long wavelength side (580 nm to 700 nm), it is considered that the skin color correction effect was sufficiently obtained. In Example 1, the reflectance was higher in the measured wavelength region than in Comparative Example 1 and Comparative Examples 3 to 6, and the reflectance was particularly high at a wavelength of 580 to 700 nm. From this, it is considered that the skin color correction effect is sufficiently obtained. Since Comparative Example 2 uses a red dye-coated pearl pigment as the component (A), the reflectance on the long wavelength side was high, but in the wavelength region other than the long wavelength, the reflectance was higher than that of Example 1. It was low and, as described above, the makeup effect was insufficiently durable.
[実施例6:水中油型乳化化粧下地の調製]
(組成) (質量%)
(1) ステアリン酸 3.0
(2) ベヘニルアルコール 2.0
(3) モノオレイン酸ポリオキシエチレンソルビタン 1.0
(4) セスキオレイン酸ソルビタン 0.5
(5) メトキシケイヒ酸エチルへキシル 5.0
(6) イソノナン酸イソノニル 3.0
(7) デカメチルシクロペンタシロキサン 2.0
(8) ローズヒップ油 1.0
(9) 酢酸トコフェロール 0.1
(10)微粒子酸化チタン[(B)成分](*4) 5.0
(11)シリコーン処理フラメンコシルクレッド[(A)成分] 3.0
(12)シリコーン処理フラメンコシルクオレンジ[(A)成分] 1.0
(13)シリコーン処理黄色酸化鉄 0.2
(14)シリコーン処理ベンガラ 0.1
(15)無水ケイ酸 3.0
(16)シリコーン処理タルク 2.7
(17)1,3−ブチレングリコール 8.0
(18)ペンチレングリコール 3.0
(19)トリエタノールアミン 0.5
(20)フェノキシエタノール 0.3
(21)ヒアルロン酸ナトリウム 0.1
(22)ハマメリス抽出液 0.1
(23)キサンタンガム 0.2
(24)カルボマー 0.1
(25)精製水 残余
[Example 6: Preparation of oil-in-water emulsified cosmetic base]
(Composition) (mass%)
(1) Stearic acid 3.0
(2) Behenyl alcohol 2.0
(3) Polyoxyethylene sorbitan monooleate 1.0
(4) Sorbitan sesquioleate 0.5
(5) Ethyl hexyl methoxycinnamate 5.0
(6) Isononyl isononanoate 3.0
(7) Decamethylcyclopentasiloxane 2.0
(8) Rosehip oil 1.0
(9) Tocopherol acetate 0.1
(10) Fine particle titanium oxide [component (B)] (* 4) 5.0
(11) Silicone-treated flamenco silk red [component (A)] 3.0
(12) Silicone-treated flamenco silk orange [component (A)] 1.0
(13) Silicone-treated yellow iron oxide 0.2
(14) Silicone-treated Bengala 0.1
(15) Silicic anhydride 3.0
(16) Silicone-treated talc 2.7
(17) 1,3-butylene glycol 8.0
(18) Pentylene glycol 3.0
(19) Triethanolamine 0.5
(20) Phenoxyethanol 0.3
(21) Sodium hyaluronate 0.1
(22) Hamelis extract 0.1
(23) Xanthan gum 0.2
(24) Carbomer 0.1
(25) Purified water residue
(製法)
A:成分(1)〜(9)を加熱し、溶解混合する。
B:成分(10)〜(16)をヘンシェルミキサー(三井鉱山社製FM−10)で均一分散をする。
C:AにBを添加して加熱混合する。
D:成分(17)〜(25)を加熱し、溶解混合する。
E:CにDをゆっくり加えて乳化混合する。
F:Eを容器に充填し、水中油型乳化化粧下地を得た。
(Manufacturing method)
A: Components (1) to (9) are heated and dissolved and mixed.
B: Components (10) to (16) are uniformly dispersed using a Henschel mixer (FM-10 manufactured by Mitsui Mining Co., Ltd.).
C: Add B to A and mix by heating.
D: Components (17) to (25) are heated and dissolved and mixed.
E: D is slowly added to C and emulsified and mixed.
F: E was filled in a container to obtain an oil-in-water emulsified makeup base.
(評価)
得られた水中油型乳化化粧下地について、実施例1〜5及び比較例1〜6と同様の評価を行ったところ、全ての項目で優れたメイクアップ化粧料であった。
(Evaluation)
About the obtained oil-in-water type emulsified makeup base, when the same evaluation as Examples 1-5 and Comparative Examples 1-6 was performed, it was the makeup cosmetics excellent in all the items.
[実施例7:油中水型乳化コンシーラーの調製]
(組成) (質量%)
(1) デカメチルシクロペンタシロキサン 12.5
(2) ジエチルヘキサン酸ネオペンチルグリコール 5.0
(3) PEG−9ポリジメチルシロキシエチルジメチコン 3.0
(4) スクワラン 3.0
(5) イソステアリン酸ソルビタン 1.0
(6) 架橋型メチルポリシロキサン(*2) 1.0
(7) ジメチルジステアリルアンモニウムヘクトライト 0.7
(8) マカデミアナッツ脂肪酸フィトステリル 0.5
(9) オリーブ油 0.3
(10)コエンザイムQ10 0.03
(11)顔料級二酸化チタン(*3) 8.0
(12)微粒子二酸化チタン[(B)成分](*4) 3.0
(13)微粒子酸化亜鉛[(B)成分](*9) 3.0
(14)シリコーン処理フラメンコシルクレッド[(A)成分] 2.0
(15)シリコーン処理ロナフレアバランスゴールド 0.5
(16)ポリメチルシルセスキオキサン 1.5
(17)シリコーン処理タルク 0.2
(18)シリコーン処理黄色酸化鉄 1.9
(19)シリコーン処理ベンガラ 0.8
(20)シリコーン処理黒色酸化鉄 0.1
(21)精製水 残余
(22)グリセリン 5.0
(23)プロピレングリコール 3.0
(24)ビスPEG−18メチルエーテルジメチルシラン 2.0
(25)塩化ナトリウム 1.0
(26)メチルパラベン 0.3
(27)フェノキシエタノール 0.3
(28)エタノール 3.0
*9:MZY−153S(テイカ社製 ハイドロゲンジメチコン処理 平均粒子径0.08μm)
[Example 7: Preparation of water-in-oil emulsification concealer]
(Composition) (mass%)
(1) Decamethylcyclopentasiloxane 12.5
(2) Diethylhexanoic acid neopentyl glycol 5.0
(3) PEG-9 polydimethylsiloxyethyl dimethicone 3.0
(4) Squalane 3.0
(5) Sorbitan isostearate 1.0
(6) Cross-linked methylpolysiloxane (* 2) 1.0
(7) Dimethyl distearyl ammonium hectorite 0.7
(8) Macadamia nut fatty acid phytosteryl 0.5
(9) Olive oil 0.3
(10) Coenzyme Q10 0.03
(11) Pigment grade titanium dioxide (* 3) 8.0
(12) Fine particle titanium dioxide [component (B)] (* 4) 3.0
(13) Fine zinc oxide [component (B)] (* 9) 3.0
(14) Silicone-treated flamenco silk red [component (A)] 2.0
(15) Silicone-treated Lona Flare Balance Gold 0.5
(16) Polymethylsilsesquioxane 1.5
(17) Silicone-treated talc 0.2
(18) Silicone-treated yellow iron oxide 1.9
(19) Silicone-treated Bengala 0.8
(20) Silicone-treated black iron oxide 0.1
(21) Purified water Residual (22) Glycerin 5.0
(23) Propylene glycol 3.0
(24) BisPEG-18 methyl ether dimethylsilane 2.0
(25) Sodium chloride 1.0
(26) Methylparaben 0.3
(27) Phenoxyethanol 0.3
(28) Ethanol 3.0
* 9: MZY-153S (Hydrogen dimethicone treatment, average particle size 0.08 μm, manufactured by Teica)
(製法)
A:成分(1)〜(10)を加熱し、溶解混合する。
B:成分(11)〜(20)をヘンシェルミキサー(三井鉱山社製FM−10)で均一分散をする。
C:AにBを添加して加熱混合する。
D:成分(21)〜(27)を加熱し、溶解混合する。
E:CにDをゆっくり加えて乳化混合する。
F:Eを45℃以下まで冷却して(28)を加え、混合する。
G:Fを容器に充填し、油中水型乳化コンシーラーを得た。
(Manufacturing method)
A: Components (1) to (10) are heated and dissolved and mixed.
B: Components (11) to (20) are uniformly dispersed with a Henschel mixer (FM-10 manufactured by Mitsui Mining Co., Ltd.).
C: Add B to A and mix by heating.
D: Components (21) to (27) are heated and dissolved and mixed.
E: D is slowly added to C and emulsified and mixed.
F: E is cooled to 45 ° C. or lower, and (28) is added and mixed.
G: F was filled in a container to obtain a water-in-oil emulsified concealer.
(評価)
得られた油中水型乳化コンシーラーについて、実施例1〜5及び比較例1〜6と同様の評価を行ったところ、全ての項目に優れたメイクアップ化粧料であった。
(Evaluation)
The obtained water-in-oil emulsified concealer was evaluated in the same manner as in Examples 1 to 5 and Comparative Examples 1 to 6, and was a makeup cosmetic excellent in all items.
[実施例8:ケーキ状パウダーファンデーションの調製]
(組成) (質量%)
(1) メトキシケイヒ酸エチルヘキシル 6.0
(2) スクワラン 3.0
(3) メチルポリシロキサン 2.0
(4) セスキイソステアリン酸ソルビタン 1.0
(5) メチルパラベン 0.3
(6) フェノキシエタノール 0.2
(7) トコフェロール 0.1
(8) セリサイト 残余
(9) タルク 20.0
(10)マイカ 10.0
(11)窒化ホウ素 5.0
(12)ナイロン末 5.0
(13)シリコーン処理顔料級二酸化チタン 5.0
(14)シリコーン処理シャロンマイクロレッド[(A)成分](平均粒径8μm) 5.0
(15)微粒子酸化亜鉛[(B)成分](*9) 5.0
(16)シリコーン処理黄色酸化鉄 1.5
(17)シリコーン処理ベンガラ 0.4
(18)シリコーン処理黒色酸化鉄 0.1
[Example 8: Preparation of cake-like powder foundation]
(Composition) (mass%)
(1) Ethylhexyl methoxycinnamate 6.0
(2) Squalane 3.0
(3) Methylpolysiloxane 2.0
(4) Sorbitan sesquiisostearate 1.0
(5) Methylparaben 0.3
(6) Phenoxyethanol 0.2
(7) Tocopherol 0.1
(8) Sericite Residual (9) Talc 20.0
(10) Mica 10.0
(11) Boron nitride 5.0
(12) Nylon powder 5.0
(13) Silicone-treated pigment grade titanium dioxide 5.0
(14) Silicone-treated Sharon Micro Red [component (A)] (average particle size 8 μm) 5.0
(15) Fine zinc oxide [component (B)] (* 9) 5.0
(16) Silicone-treated yellow iron oxide 1.5
(17) Silicone-treated Bengala 0.4
(18) Silicone-treated black iron oxide 0.1
(製法)
A:成分(1)〜(7)を加熱し、溶解混合する。
B:成分(8)〜(18)をヘンシェルミキサー(三井鉱山社製FM−10)で均一分散をする。
C:AをBに添加してヘンシェルミキサーで均一分散をする。
D:得られた混合物を60メッシュの篩に通す。
E:金皿に充填し、圧縮成型して、ケーキ状パウダーファンデーションを得た。
(Manufacturing method)
A: Components (1) to (7) are heated and dissolved and mixed.
B: Components (8) to (18) are uniformly dispersed with a Henschel mixer (FM-10 manufactured by Mitsui Mining Co., Ltd.).
C: A is added to B and uniformly dispersed with a Henschel mixer.
D: The obtained mixture is passed through a 60 mesh sieve.
E: Filled into a metal pan and compression molded to obtain a cake-like powder foundation.
(評価)
得られたケーキ状パウダーファンデーションについて、実施例1〜5及び比較例1〜6と同様の評価を行ったところ、全ての項目に優れたメイクアップ化粧料であった。
(Evaluation)
About the obtained cake-form powder foundation, when the same evaluation as Examples 1-5 and Comparative Examples 1-6 was performed, it was makeup cosmetics excellent in all the items.
[実施例9:油性スティック状ファンデーションの調製]
(組成) (質量%)
(1) デカメチルシクロペンタシロキサン 残余
(2) ジフェニルシロキシフェニルトリメチコン 15.0
(3) トリオクタノイン 10.0
(4) トリイソステアリン酸ポリグリセリル−2 7.0
(5) セスキイソステアリン酸ソルビタン 1.0
(6) セレシン 6.0
(7) マイクロクリスタリンワックス 5.0
(8) キャンデリラロウ 2.0
(9) トコフェロール 0.1
(10)シリコーン処理タルク 3.0
(11)シリコーン処理セリサイト 3.0
(12)ポリメタクリル酸メチル 3.0
(13)シリコーン処理顔料級二酸化チタン 7.0
(14)シリコーン処理フラメンコシルクオレンジ[(A)成分] 5.0
(15)微粒子酸化チタン[(B)成分](*4) 3.0
(16)シリコーン処理ベンガラ 0.4
(17)シリコーン処理黄色酸化鉄 1.5
(18)シリコーン処理黒色酸化鉄 0.1
[Example 9: Preparation of oily stick-like foundation]
(Composition) (mass%)
(1) Decamethylcyclopentasiloxane Residue (2) Diphenylsiloxyphenyl trimethicone 15.0
(3) Trioctanoin 10.0
(4) Polyglyceryl-2 triisostearate 7.0
(5) Sorbitan sesquiisostearate 1.0
(6) Ceresin 6.0
(7) Microcrystalline wax 5.0
(8) Candelilla wax 2.0
(9) Tocopherol 0.1
(10) Silicone-treated talc 3.0
(11) Silicone-treated sericite 3.0
(12) Polymethyl methacrylate 3.0
(13) Silicone-treated pigment grade titanium dioxide 7.0
(14) Silicone-treated flamenco silk orange [component (A)] 5.0
(15) Fine particle titanium oxide [component (B)] (* 4) 3.0
(16) Silicone-treated Bengala 0.4
(17) Silicone-treated yellow iron oxide 1.5
(18) Silicone-treated black iron oxide 0.1
(製法)
A:成分(1)〜(9)を加熱し、溶解混合した。
B:成分(10)〜(18)をヘンシェルミキサー(三井鉱山社製FM−10)で均一に分散した。
C:AにBを添加して加熱混合した。
D:Cを容器に充填し、冷却して油性スティック状ファンデーションを得た。
(Manufacturing method)
A: Components (1) to (9) were heated and dissolved and mixed.
B: Components (10) to (18) were uniformly dispersed with a Henschel mixer (FM-10 manufactured by Mitsui Mining Co., Ltd.).
C: B was added to A and mixed by heating.
D: C was filled into a container and cooled to obtain an oily stick-like foundation.
(評価)
得られた油性スティック状ファンデーションをについて、実施例1〜5及び比較例1〜6と同様の評価を行ったところ、全ての項目に優れたメイクアップ化粧料であった。
(Evaluation)
About the obtained oil-based stick-like foundation, when evaluation similar to Examples 1-5 and Comparative Examples 1-6 was performed, it was makeup cosmetics excellent in all the items.
Claims (5)
成分(B)平均一次粒子径が0.05μm〜0.12μmの範囲にある微粒子金属酸化物と
を含有するメイクアップ化粧料。 Component (A) one or more pearl pigments exhibiting an orange or red interference color having an average particle size of 1.0 to 15.0 μm;
A makeup cosmetic containing a component (B) a fine particle metal oxide having an average primary particle diameter in the range of 0.05 μm to 0.12 μm.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015174696A JP6758033B2 (en) | 2015-09-04 | 2015-09-04 | Makeup cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015174696A JP6758033B2 (en) | 2015-09-04 | 2015-09-04 | Makeup cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2017048158A true JP2017048158A (en) | 2017-03-09 |
JP6758033B2 JP6758033B2 (en) | 2020-09-23 |
Family
ID=58279098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015174696A Active JP6758033B2 (en) | 2015-09-04 | 2015-09-04 | Makeup cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6758033B2 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018199160A1 (en) * | 2017-04-28 | 2018-11-01 | 株式会社 資生堂 | Water-in-oil type emulsification cosmetic makeup preparation |
JP2021091677A (en) * | 2019-12-06 | 2021-06-17 | シャネル パフュームズ ビューテ | Cosmetic composition with metallic effect |
JP2021104933A (en) * | 2019-12-13 | 2021-07-26 | ロレアル | Powdery cosmetic composition |
WO2022019144A1 (en) * | 2020-07-22 | 2022-01-27 | 株式会社 資生堂 | Cosmetic preparation |
JP2022024445A (en) * | 2020-07-28 | 2022-02-09 | 花王株式会社 | Water-in-oil emulsified cosmetic |
WO2022224672A1 (en) * | 2021-04-21 | 2022-10-27 | 株式会社 資生堂 | Oil-in-water emulsified cosmetic material |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11116441A (en) * | 1997-10-07 | 1999-04-27 | Kao Corp | Cosmetics |
JP2000319156A (en) * | 1999-05-12 | 2000-11-21 | Kao Corp | UV protection |
JP2002003357A (en) * | 2000-06-19 | 2002-01-09 | Fancl Corp | Sunscreen cosmetics |
JP2002241231A (en) * | 2001-02-20 | 2002-08-28 | Nippon Shikizai Inc | Cosmetic or skin treating agent |
JP2003171232A (en) * | 2001-12-10 | 2003-06-17 | Kao Corp | Lip cosmetics |
JP6514859B2 (en) * | 2014-06-05 | 2019-05-15 | 株式会社ディーエイチシー | Makeup cosmetics |
-
2015
- 2015-09-04 JP JP2015174696A patent/JP6758033B2/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11116441A (en) * | 1997-10-07 | 1999-04-27 | Kao Corp | Cosmetics |
JP2000319156A (en) * | 1999-05-12 | 2000-11-21 | Kao Corp | UV protection |
JP2002003357A (en) * | 2000-06-19 | 2002-01-09 | Fancl Corp | Sunscreen cosmetics |
JP2002241231A (en) * | 2001-02-20 | 2002-08-28 | Nippon Shikizai Inc | Cosmetic or skin treating agent |
JP2003171232A (en) * | 2001-12-10 | 2003-06-17 | Kao Corp | Lip cosmetics |
JP6514859B2 (en) * | 2014-06-05 | 2019-05-15 | 株式会社ディーエイチシー | Makeup cosmetics |
Non-Patent Citations (1)
Title |
---|
桑原章郎他: "化粧品に用いられる顔料", 粉体工学会誌, vol. 23, no. 4, JPN6019020470, 1986, pages 262 - 273, ISSN: 0004218564 * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018199160A1 (en) * | 2017-04-28 | 2018-11-01 | 株式会社 資生堂 | Water-in-oil type emulsification cosmetic makeup preparation |
US11400033B2 (en) | 2017-04-28 | 2022-08-02 | Shiseido Company, Ltd. | Water-in-oil type emulsification cosmetic |
JP2021091677A (en) * | 2019-12-06 | 2021-06-17 | シャネル パフュームズ ビューテ | Cosmetic composition with metallic effect |
JP2021104933A (en) * | 2019-12-13 | 2021-07-26 | ロレアル | Powdery cosmetic composition |
CN114760974A (en) * | 2019-12-13 | 2022-07-15 | 莱雅公司 | Powdery cosmetic composition |
WO2022019144A1 (en) * | 2020-07-22 | 2022-01-27 | 株式会社 資生堂 | Cosmetic preparation |
JP2022021511A (en) * | 2020-07-22 | 2022-02-03 | 株式会社 資生堂 | Cosmetics |
JP7611658B2 (en) | 2020-07-22 | 2025-01-10 | 株式会社 資生堂 | Cosmetics |
JP2022024445A (en) * | 2020-07-28 | 2022-02-09 | 花王株式会社 | Water-in-oil emulsified cosmetic |
WO2022224672A1 (en) * | 2021-04-21 | 2022-10-27 | 株式会社 資生堂 | Oil-in-water emulsified cosmetic material |
JP2022166758A (en) * | 2021-04-21 | 2022-11-02 | 株式会社 資生堂 | Oil-in-water emulsified cosmetic material |
Also Published As
Publication number | Publication date |
---|---|
JP6758033B2 (en) | 2020-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6033587B2 (en) | Polyester and cosmetics using the same | |
JP7084164B2 (en) | Cosmetics containing sparingly soluble ingredients | |
JP6514859B2 (en) | Makeup cosmetics | |
US20170049667A1 (en) | Composition comprising microcapsules containing particles with a high wet point | |
JP2018123129A (en) | Cosmetic | |
WO2012133787A1 (en) | Method for producing cosmetic, method for preparing gel for cosmetics, and method for reducing quantity of high-molecular thickener added to starting materials of cosmetic | |
JP5143354B2 (en) | Oligomer ester and cosmetics and skin external preparations containing these | |
JP2017155034A (en) | Alternative oil agents for low molecular weight silicone oil | |
JP6359295B2 (en) | Water-in-oil emulsified cosmetic and method for producing the same | |
JP5334720B2 (en) | Oily base and cosmetics and skin external preparations containing the same | |
JP4931568B2 (en) | Cosmetics containing surface-treated powder | |
JP2013067594A (en) | Cosmetic containing prunus persica gum | |
JP2020176067A (en) | Cosmetics containing phosphatidylinositol or topical skin preparations | |
JP7129768B2 (en) | surface treatment powder | |
JP2018087148A (en) | γ-Oryzanol-containing cosmetics | |
JP2020158400A (en) | O/w emulsion composition | |
JP6758033B2 (en) | Makeup cosmetics | |
JP2019189556A (en) | Phosphatidylinositol-containing complex | |
JP2020158398A (en) | Cosmetic containing isosorbide derivative | |
WO2021020560A1 (en) | Pigment including cellulose | |
JP5805466B2 (en) | Diester composition for cosmetics or external preparation for skin having lamella forming ability | |
JP5726481B2 (en) | Cosmetic or skin external preparation containing hydroxynicotinic acid or a derivative thereof | |
KR102715221B1 (en) | Make-up cosmetic composition comprising scoria powder | |
JP2014210711A (en) | Hyaluronic acid production promoter | |
JP5602456B2 (en) | Ascorbic acid derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180815 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190604 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20190531 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20190731 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190920 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200221 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200417 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20200804 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200901 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6758033 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |